Processing 00000000.tx.1: -Synuclein Interacts with Phospholipase D Isozymes and Inhibits Pervanadate-induced Phospholipase D Activation in Human Embryonic Kidney-293 Cells* Bong-Hyun Ahna, Hyangshuk Rhimb, Shi Yeon Kima, Young-Mo Sungc, Mun-Yong Leed, Ju-Youn Choib, Benjamin Wolozine, Jong-Soo Changf, Young Han Leeg, Taeg Kyu Kwonh, Kwang Chul Chungi, Shin-Hee Yoona, Sang June Hahna, Myung-Suk Kima, Yang-Hyeok Joa, and Do Sik Minaj From the aDepartment of Physiology, bResearch Institute of Molecular Genetics, and dAnatomy, College of Medicine, The Catholic University of Korea, Seoul 137-701,Korea, the cGraduate School of Biotechnology, Korea University, Seoul 136-701,Korea, the eDepartment of Pharmacology, Loyola University Medical Center, Maywood, Illinois 60153,the fDepartment of Life Science, Daejin University, Pochon-gun 487-800,Kyeongggido, Korea, the gDepartment of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu 705-717,Korea, the hDepartment of Immunology, School of Medicine, Keimyung University, Daegu 700-712,Korea, and the iDepartment of Pharmacology, Yonsei University College of Medicine, Seoul 120-752,Korea Received for publication, October 30,2001, and in revised form, January 22,2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein has been implicated in the pathogenesis of many neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Interacts with Phospholipase D Isozymes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0022173:Isozymes [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Pervanadate-induced Phospholipase D Activation in Human Embryonic Kidney-293 Cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1326120:activation cells [Cell Function]
   738   C1879547:Activation [Activity]

Phrase: "* Bong-Hyun Ahna,"

Phrase: "Hyangshuk Rhimb,"

Phrase: "Shi Yeon Kima,"

Phrase: "Young-Mo Sungc,"

Phrase: "Mun-Yong Leed,"

Phrase: "Ju-Youn Choib,"

Phrase: "Benjamin Wolozine,"

Phrase: "Jong-Soo Changf,"

Phrase: "Young Han Leeg,"

Phrase: "Taeg Kyu Kwonh,"

Phrase: "Kwang Chul Chungi,"

Phrase: "Shin-Hee Yoona,"

Phrase: "Sang"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1864650:SANG [Gene or Genome]
   966 E C0037173:SING [Geographic Area]
   966 E C0234857:sing [Individual Behavior]

Phrase: "June Hahna,"

Phrase: "Myung-Suk Kima,"

Phrase: "Yang-Hyeok Joa,"

Phrase: "and"

Phrase: "Do"

Phrase: "Sik Minaj From the aDepartment of Physiology,"

Phrase: "bResearch Institute of Molecular Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "dAnatomy,"

Phrase: "College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0557806:College [Manufactured Object]

Phrase: "The Catholic University of Korea,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0022771:Korea [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0242211:Catholic [Population Group]
   812   C0871674:catholic [Population Group]
   741 E C1556095:Korean [Population Group]

Phrase: "Seoul 137-701,"

Phrase: "Korea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "the cGraduate School of Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Korea University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Seoul 136-701,"

Phrase: "Korea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "the eDepartment of Pharmacology,"

Phrase: "Loyola University Medical Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: "Maywood,"

Phrase: "Illinois 60153,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020898:Illinois [Geographic Area]

Phrase: "the fDepartment of Life Science,"

Phrase: "Daejin University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Pochon-gun 487-800,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018397:gun [Manufactured Object]

Phrase: "Kyeongggido,"

Phrase: "Korea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "the gDepartment of Biochemistry"

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0557806:College [Manufactured Object]

Phrase: "Yeungnam University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Daegu 705-717,"

Phrase: "Korea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "the hDepartment of Immunology,"

Phrase: "School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036375:School [Manufactured Object,Organization]

Phrase: "Keimyung University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Daegu 700-712,"

Phrase: "Korea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "and"

Phrase: "the iDepartment of Pharmacology,"

Phrase: "Yonsei University College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0557806:College [Manufactured Object]

Phrase: "Seoul 120-752,"

Phrase: "Korea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "October 30,"

Phrase: "2001,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "January 22,"

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the pathogenesis of many neurodegenerative diseases,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   744   C0012634:Diseases [Disease or Syndrome]
   744   C0543483:pathogenesis [Functional Concept]
   744   C0699748:Pathogenesis [Pathologic Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.2: Although the function of -synuclein remains largely unknown, recent studies have demonstrated that this protein can interact with phospholipids. 

Phrase: "Although"

Phrase: "the function of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "remains"

Phrase: "largely unknown, recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "interact with phospholipids."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   756 E C0202177:Phospholipid [Laboratory Procedure]
Processing 00000000.tx.3: To address the role of -synuclein in neurodegenerative disease, we have investigated whether it binds phospholipase D (PLD) and affects PLD activity in human embryonic kidney (HEK)-293 cells overexpressing wild type -synuclein or the mutant forms of -synuclein (A53T, A30P) associated with Parkinson's disease. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the role of -synuclein in neurodegenerative disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "it"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "phospholipase D (PLD)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "PLD activity in human embryonic kidney (HEK)-293 cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1149851:phospholipase D activity [Molecular Function]
   762   C0020115:Human Activity [Activity]
   762   C1149838:phospholipase activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "wild type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "the mutant forms of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A53T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "A30P)"

Phrase: "associated with Parkinson's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.4: Tyrosine phosphorylation of -synuclein appears to play a modulatory role in the inhibition of PLD, because mutation of Tyr125 to Phe slightly increases inhibitory effect of -synuclein on PLD activity. 

Phrase: "Tyrosine phosphorylation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a modulatory role in the inhibition of PLD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "because"

Phrase: "mutation of Tyr125"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to Phe slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031453:Phe [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "inhibitory effect of -synuclein on PLD activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.5: Treatment with pervanadate or phorbol myristate acetate inhibits PLD more in HEK 293cells overexpressing -synuclein than in control cells. 

Phrase: "Treatment with pervanadate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "phorbol myristate acetate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PLD more in HEK 293cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in control cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: Binding of -synuclein to PLD requires phox and pleckstrin homology domain of PLD and the amphipathic repeat region and non-A component of -synuclein. 

Phrase: "Binding of -synuclein to PLD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "requires"

Phrase: "phox"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0768581:phOx [Organic Chemical]

Phrase: "and"

Phrase: "pleckstrin homology domain of PLD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1518792:Pleckstrin-Homology Domain [Amino Acid Sequence]
   753   C0071246:pleckstrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1334043:Homology [Gene or Genome]
   753   C1418644:PLECKSTRIN [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C2697616:Homology [Qualitative Concept]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the amphipathic repeat region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "non-A component of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.7: Although biologically important, co-transfection studies indicate that the interaction of -synuclein with PLD does not influence the tendency of -synuclein to form pathological inclusions. 

Phrase: "Although"

Phrase: "biologically important, co-transfection studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the interaction of -synuclein with PLD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the tendency of -synuclein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "pathological inclusions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.8: These results suggest that the association of -synuclein with PLD, and modulation of PLD activity, is biologically important, but PLD does not appear to play an essential role in the pathophysiology of -synuclein.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the association of -synuclein with PLD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "modulation of PLD activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "is"

Phrase: "biologically important,"

Phrase: "but"

Phrase: "PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an essential role in the pathophysiology of -synuclein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein is a small, highly conserved presynaptic protein of unknown function that has been implicated in the development of neurodegenerative diseases, such as Alzheimer's (AD)1 and Parkinson's disease (PD). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a small, highly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205250:Highly [Qualitative Concept]
   861   C0700321:Small [Quantitative Concept]

Phrase: "conserved"

Phrase: "presynaptic protein of unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the development of neurodegenerative diseases,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "such as Alzheimer's (AD)1"

Phrase: "and"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD"

Phrase: ")."
Processing 00000000.tx.10: -Synuclein is known to be a structural component of the filaments in Lewy bodies of PD and dementia with Lewy bodies (1-5). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a structural component of the filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "in Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "of PD"

Phrase: "and"

Phrase: "dementia with Lewy bodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(1-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: -Synuclein also contributes to the intracellular inclusions of multiple system atrophy (6, 7), and a fragment has been found in senile plaques in Alzheimer's disease. 

Phrase: "-Synuclein also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contributes to the intracellular inclusions of multiple system atrophy"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0037019:Multiple System Atrophy [Disease or Syndrome]
   790   C0393571:Multiple System Atrophy [Disease or Syndrome]
   742   C0175996:intracellular [Cell Component]
   742   C0178719:Intracellular [Spatial Concept]
   742   C0333641:Atrophy [Pathologic Function]
   742   C0439064:Multiple [Quantitative Concept]
   742   C0449913:System [Functional Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   742   C1880177:Contribute [Activity]
   708   C1512693:Inclusion [Qualitative Concept]

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "found in senile plaques"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   770   C0150312:Found [Quantitative Concept]
   770   C0392079:Senile [Finding]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0243095:Find [Finding]
   737 E C0332461:Plaque [Finding]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.12: Two point mutations (A53T, A30P) in -synuclein are genetically linked to familial PD (8, 9). 

Phrase: "Two point mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(A53T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "A30P) in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "genetically"

Phrase: "linked to familial PD (8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.13: However, the mechanism by which -synuclein is involved in PD and in the accumulation in Lewy bodies remains elusive. 

Phrase: "However,"

Phrase: "the mechanism by which -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "involved in PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]

Phrase: "and in the accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "in Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "remains"

Phrase: "elusive."
Processing 00000000.tx.14: The recent observation that both mice and flies expressing a human -synuclein transgene recapitulate some characteristics of PD suggests that -synuclein could be involved directly in the development of this disease (10, 11). 

Phrase: "The recent observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "both mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "flies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012578:Flies [Eukaryote]
   966 E C1704307:Fly [Eukaryote]

Phrase: "expressing"

Phrase: "a human -synuclein transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282641:Transgene [Gene or Genome]

Phrase: "recapitulate"

Phrase: "some characteristics of PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristics [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "be"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "directly in the development of this disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0012634:Disease [Disease or Syndrome]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   748   C1947931:Directly [Qualitative Concept]

Phrase: "(10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.15: Structurally, -synuclein is a small acidic protein of 140amino acid residues that contains three modular domain, including an amino-terminal lipid binding -helix, an amyloid binding domain that encodes the non-A component (NAC) of AD plaques, and a carboxyl-terminal acidic tail. 

Phrase: "Structurally, -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a small acidic protein of 140amino acid residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1824324:small acidic protein [Gene or Genome]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "three modular domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an amino-terminal lipid binding -helix,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0018882:Helix [Eukaryote]
   804   C0229304:Helix [Body Part, Organ, or Organ Component]
   804   C1704821:Helix [Spatial Concept]
   804   C1705682:Helix [Anatomical Structure]
   722   C3154958:amino-terminal binding [Molecular Function]

Phrase: "an amyloid binding domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "the non-A component (NAC) of AD plaques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "a carboxyl-terminal acidic tail."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0039259:Tail [Body Part, Organ, or Organ Component]
Processing 00000000.tx.16: The structure of -synuclein allows the molecule to exist in either a random or a natively unfolded conformation or as an -helix in the presence of phospholipids (12, 13), suggesting a highly dynamic regulation of -synuclein function that depends on the local cellular milieu. 

Phrase: "The structure of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the molecule to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "exist in either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2987476:Exist [Conceptual Entity]

Phrase: "a random"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034656:RANDOM [Research Activity]
  1000   C0439605:Random [Qualitative Concept]

Phrase: "or"

Phrase: "a natively unfolded conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "or as an -helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018882:Helix [Eukaryote]
   770   C0229304:Helix [Body Part, Organ, or Organ Component]
   770   C1704821:Helix [Spatial Concept]
   770   C1705682:Helix [Anatomical Structure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   966 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "(12,"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a highly dynamic regulation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "depends on the local cellular milieu."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   753   C0205276:Local [Spatial Concept]
   753   C0725813:depend [Medical Device]
Processing 00000000.tx.17: Reported binding targets for -synuclein include Tau (14), 14-3-3(15), protein kinase C (15), synphilin-1 (16), Elk (17), Tat-binding protein 1(18). 

Phrase: "Reported binding targets for -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "14-3-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0090388:14-3-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421563:14-3-3 [Gene or Genome]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "Elk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325228:Elk [Mammal]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "Tat-binding protein 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1419022:TAT-BINDING PROTEIN 1 [Gene or Genome]
   875   C0039341:tat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.18: Recent studies have suggested various cellular roles for -synuclein that include possible modifications of membrane and cell surface signaling events (19). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested various cellular roles for -synuclein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "that"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "possible modifications of membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "cell surface signaling events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441471:Events [Event]
   812   C3541888:Events [Classification]
   708   C0037083:Cell Signaling [Cell Function]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.19: Although normal cellular functions of -synuclein are unknown, several observations suggest the synuclein may serve to integrate presynaptic signaling and membrane trafficking. 

Phrase: "Although"

Phrase: "normal cellular functions of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "unknown, several observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0302523:observations [Research Activity]
   827   C0700325:observations [Health Care Activity]
   827   C3244290:observations [Functional Concept]
   793 E C1964257:Observation [Diagnostic Procedure]
   743 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "integrate"

Phrase: "presynaptic signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "trafficking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]
Processing 00000000.tx.20: Recently, -synuclein has been identified as a potent and selective inhibitor of phospholipase D2 (PLD2) in vitro. 

Phrase: "Recently, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "identified as a potent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "selective inhibitor of phospholipase D2 (PLD2)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0597220:phospholipase inhibitor [Pharmacologic Substance]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.21: PLD hydrolyzes phosphatidylcholine to produce phosphatidic acid and diacylglycerol (20). 

Phrase: "PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "hydrolyzes"

Phrase: "phosphatidylcholine to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   805 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   805 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: "produce"

Phrase: "phosphatidic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "diacylglycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043791:Diacylglycerol [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.22: This suggests that the level and modification of -synuclein may affect phospholipase D2 activity in vitro, thereby modulating the cleavage of membrane lipids and membrane biogenesis (19). 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "modification of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "phospholipase D2 activity in vitro, thereby"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   839   C1149838:phospholipase activity [Molecular Function]
   827   C0021135:In Vitro [Intellectual Product]
   827   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   827   C1533691:in vitro [Qualitative Concept]
           vitro
   827   C2827718:In Vitro [Functional Concept]
   799   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1414052:D2 [Gene or Genome]
   799   C1415944:D2 [Gene or Genome]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "the cleavage of membrane lipids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "membrane biogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596898:membrane biogenesis [Cell Function]
   861   C0005495:Biogenesis [Natural Phenomenon or Process]
   861   C0220781:Biogenesis [Biologic Function]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.23: Thus far, two isoforms of PLD have been described, PLD1 and PLD2 (21-24). 

Phrase: "Thus far,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "two isoforms of PLD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "and"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "(21-24"

Phrase: ")."
Processing 00000000.tx.24: Activity of 120-kDa PLD1 is regulated by multiple inputs, including phosphatidylinositol 4,5-bisphosphate, protein kinase C, the Rho family proteins, and ADP-ribosylation factor proteins. 

Phrase: "Activity of 120-kDa PLD1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "regulated by multiple inputs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439064:Multiple [Quantitative Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   737   C1708517:Input [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "phosphatidylinositol 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-bisphosphate,"

Phrase: "protein kinase C,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the Rho family proteins,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0015576:Family [Family Group]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "ADP-ribosylation factor proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0101671:ADP-Ribosylation Factor [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1527266:ADP-Ribosylation Factor [Conceptual Entity]
Processing 00000000.tx.25: PLD2 is a 106-kDa protein that share 50-55% homology with PLD1. 

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "is"

Phrase: "a 106-kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that share 50-55% homology with PLD1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1334043:Homology [Gene or Genome]
   748   C2697616:Homology [Qualitative Concept]
Processing 00000000.tx.26: PLD2 is reported to have a much higher basal activity than PLD1 and appears to be insensitive to further stimulation by the known activators of PLD1. 

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a much higher basal activity than PLD1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "insensitive to further stimulation"

Phrase: "by the known activators"

Phrase: "of PLD1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]
Processing 00000000.tx.27: The primary lipid product of PLD, phosphatidic acid, exhibits a number of biological activities in vitro and may be an important mediator of processes controlling vesicular transport and changes in cell morphology (25). 

Phrase: "The primary lipid product of PLD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "phosphatidic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031610:Phosphatidic Acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a number of biological activities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "an important mediator of processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "vesicular transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1325417:vesicular transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "in cell morphology"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0243091:cell morphology [Qualitative Concept]
   901   C1521816:Cell morphology [Clinical Attribute]
   901   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.28: In neuronal cells, PLD activation has been linked to pathways involved in cell growth, differentiation, and neurotransmitter release (26, 27). 

Phrase: "In neuronal cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "PLD activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1879547:Activation [Activity]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "linked to pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1704259:Pathways [Molecular Function]
   790   C1705987:Pathways [Conceptual Entity]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell growth,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007595:Cell Growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "neurotransmitter release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0598964:neurotransmitter release [Cell Function]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.29: Although many studies continue to focus on the functional relationships and the isozyme specificities of the PLD isozymes, the molecular mechanism of the regulation of the PLDs has not been fully elucidated. 

Phrase: "Although"

Phrase: "many studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "continue to focus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205234:Focus [Spatial Concept]
   790   C0549178:Continue [Idea or Concept]
   790   C1285542:focus [Functional Concept]

Phrase: "on the functional relationships"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2700217:Functional Relationship [Conceptual Entity]
   861   C0439849:Relationships [Qualitative Concept]
   827 E C1705630:Relationship [Idea or Concept]
   827 E C1706279:Relationship [Idea or Concept]
   827 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "the isozyme specificities of the PLD isozymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0037791:Specificity [Quantitative Concept]
   711   C1511884:Specificity [Quantitative Concept]

Phrase: "the molecular mechanism of the regulation of the PLDs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "fully"

Phrase: "elucidated."
Processing 00000000.tx.30: In this regard, the identification of PLD-binding partners may provide clues toward the understanding of complex regulatory mechanism of PLD in different cells. 

Phrase: "In this regard,"

Phrase: "the identification of PLD-binding partners"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "clues toward the understanding of complex regulatory mechanism of PLD"

Phrase: "in different cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.31: Since direct cell cytotoxicity of -synuclein is still controversial, -synuclein might interact with other proteins to cause neurodegeneration. 

Phrase: "Since direct cell cytotoxicity of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "still controversial, -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "interact with other proteins to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.32: The investigation of regulation of PLD by -synuclein is required to gain insight into the role of these proteins under normal and pathological condition. 

Phrase: "The investigation of regulation of PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1261322:Investigation [Health Care Activity]
   748   C1552578:investigation [Idea or Concept]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the role of these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0233820:Insight [Mental Process]

Phrase: "under normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "pathological condition."
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   861   C0012634:condition [Disease or Syndrome]
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C0348080:Condition [Qualitative Concept]
   861   C1521733:Pathological [Functional Concept]
   861   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0009647:Conditioned [Mental Process]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.33: As a step in this effort, we now report for the first time that -synuclein binds to PLD1 and PLD2 and inhibits pervanadate-induced PLD activation in human embryonic kidney 293cells. 

Phrase: "As a step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "this effort,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Effort [Organism Function]

Phrase: "we now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "report for the first time"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C1279901:First [Qualitative Concept]
   760   C3273238:Report [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to PLD1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   790   C1418641:PLD1 [Gene or Genome]

Phrase: "and"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "pervanadate-induced PLD activation in human embryonic kidney 293cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1879547:Activation [Activity]
Processing 00000000.tx.34: Moreover, we show that the state of tyrosine phosphorylation of -synuclein plays a modulatory role in pervanadate-induced PLD activity.  

Phrase: "Moreover,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the state of tyrosine phosphorylation of -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a modulatory role in pervanadate-induced PLD activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.35: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Materials-- Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum, and LipofectAMINE were purchased from Invitrogen. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "(DMEM"

Phrase: ")"

Phrase: ","

Phrase: "fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "LipofectAMINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "were"

Phrase: "purchased from Invitrogen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.36: Protein A-Sepharose and glutathione-Sepharose 4B were from Amersham Biosciences. 

Phrase: "Protein A-Sepharose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0075172:protein A-sepharose [Carbohydrate]
   827   C0036681:Sepharose [Carbohydrate]
   734   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "glutathione-Sepharose 4B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036682:Sepharose 4B [Biomedical or Dental Material,Carbohydrate]
   827   C0450375:4b [Intellectual Product]

Phrase: "were from Amersham Biosciences."
Processing 00000000.tx.37: Biotech. 

Phrase: "Biotech."
Processing 00000000.tx.38: Hydrogen peroxide and sodium orthovanadate were from Sigma, and anti-phosphotyrosine antibody (Tyr(P)) (4G10) were from Upstate Biotechnology. 

Phrase: "Hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "and"

Phrase: "sodium orthovanadate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0029366:Orthovanadate [Inorganic Chemical]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "were from Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]

Phrase: "and"

Phrase: "anti-phosphotyrosine antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1421250:TYR [Gene or Genome]

Phrase: "(P)) (4G10"

Phrase: ")"

Phrase: "were from Upstate Biotechnology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005574:Biotechnology [Biomedical Occupation or Discipline]
Processing 00000000.tx.39: The antibody to PKC was purchased from Santa Cruz. 

Phrase: "The antibody to PKC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Santa Cruz."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]
Processing 00000000.tx.40: Mouse monoclonal antibody to -synuclein was generated using GST--synuclein as an antigen. 

Phrase: "Mouse monoclonal antibody to -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GST--synuclein as an antigen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.41: Rabbit polyclonal antibody that recognizes both PLD1 and PLD2 was generated as described previously (28). 

Phrase: "Rabbit polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "recognizes"

Phrase: "both PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "and"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.42: Phosphatidylbutanol standard was from Avanti Polar Lipid. myo-[2-3H]Inositol and [9,10-3H]myristate were purchased from PerkinElmer Life Sciences. 

Phrase: "Phosphatidylbutanol standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "was from Avanti Polar Lipid. myo-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0023779:Lipid [Lipid]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0813983:polar [Quantitative Concept]
   753   C1421478:WAS [Gene or Genome]

Phrase: "[2-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]Inositol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "and ["

Phrase: "9,"

Phrase: "10-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]myristate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from PerkinElmer Life Sciences."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0005526:Life Sciences [Occupation or Discipline]
   760   C0036397:Sciences [Occupation or Discipline]
   760   C0376558:Life [Idea or Concept]
   760   C0869011:purchased [Activity]
Processing 00000000.tx.43: Silica gel 60A thin layer chromatography plates were from Whatman. 

Phrase: "Silica gel 60A thin layer chromatography plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C1139930:plates [Medical Device]
   762 E C0005971:Plate [Medical Device]
   762 E C3537155:Plate [Manufactured Object]

Phrase: "were from Whatman."
Processing 00000000.tx.44: Horseradish peroxidase-conjugated anti-mouse IgG and anti-rabbit IgG were from Kirkegaard &Perry Laboratory (Gaithersburg, MD). 

Phrase: "Horseradish peroxidase-conjugated anti-mouse IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   839   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0034493:Rabbit [Mammal]

Phrase: "were from Kirkegaard &Perry Laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "(Gaithersburg,"

Phrase: "MD)."
Processing 00000000.tx.45: The ECL Western blotting detection kit was from Amersham Biosciences. 

Phrase: "The ECL Western blotting detection kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0812225:KIT [Medical Device]
   804   C1150635:KIT [Molecular Function]
   804   C1705212:Kit [Medical Device]
   804   C1705213:KIT [Medical Device]
   804   C3273202:Kit [Manufactured Object]

Phrase: "was from Amersham Biosciences."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.46: Cell Culture and Transfection-- HEK 293cells were maintained in Hepes-buffered DMEM (Invitrogen) supplemented with 10% (v/v) fetal bovine serum under 5% CO2. 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "--"

Phrase: "HEK 293cells"

Phrase: "were"

Phrase: "maintained in Hepes-buffered DMEM"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1314677:Maintained [Functional Concept]
   726 E C0024501:Maintain [Activity]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "supplemented with 10%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "(v/v) fetal bovine serum under 5% CO2."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0036786:co2 serum [Laboratory Procedure]
   744   C0007452:Bovine [Mammal]
   744   C0015965:Fetal [Embryonic Structure]
   744   C0229671:Serum [Body Substance]
   744   C0521457:Fetal [Functional Concept]
   744   C1140701:bovine [Mammal]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
Processing 00000000.tx.47: The cells were transfected with the indicated plasmid DNA and LipofectAMINE (Invitrogen) according to manufacturer's instructions. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with the indicated plasmid DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "LipofectAMINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "according to manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.48: G418 (500g/ml) was used for selection. 

Phrase: "G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(500g/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "used for selection."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0036576:selection [Genetic Function]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.49: Co-immunoprecipitation and Immunoblot-- HEK 293cells were lysed with lysis buffer (20mM Hepes, pH 7.2,1% Triton X-100, 1% sodium deoxycholate, 0.2% SDS, 150mM NaCl, 1mM Na3VO4, 1mM NaF, 10% glycerol, 10g/ml leupeptin, 10g/ml aprotinin, 1mM phenymethylsulfonyl fluoride) and precleared with preimmune IgG and protein A-Sepharose for 30min at 4C with rocking. 

Phrase: "Co-immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Immunoblot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "--"

Phrase: "HEK 293cells"

Phrase: "were"

Phrase: "lysed with lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
           lysed
   770   C1536403:lysis [Cell Function]

Phrase: "(20mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "1% sodium deoxycholate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "0.2% SDS,"

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM Na3VO4,"

Phrase: "1mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   861   C1366571:NAF [Gene or Genome]
   861   C1705592:NAF [Gene or Genome]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "10g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "10g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1mM phenymethylsulfonyl fluoride"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "precleared with preimmune IgG"

Phrase: "and"

Phrase: "protein A-Sepharose for 30min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C0075172:protein A-sepharose [Carbohydrate]
   760   C0036681:Sepharose [Carbohydrate]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with rocking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005899:Rocking [Individual Behavior]
Processing 00000000.tx.50: Protein concentrations were determined using the Bio-Rad Protein Assay with bovine serum albumin as a standard. 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Bio-Rad Protein Assay with bovine serum albumin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0005507:Assay [Laboratory Procedure]
   742   C0243073:assay [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]

Phrase: "as a standard."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.51: Equal protein aliquots of precleared cell lysates (1mg) were incubated with the indicated antibodies and 30l of a 1:1 slurry of protein A-Sepharose beads for 4h at 4C. 

Phrase: "Equal protein aliquots of precleared cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1510844:Aliquot [Quantitative Concept]

Phrase: "(1mg"

Phrase: ")"

Phrase: "were"

Phrase: "incubated with the indicated antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "30l of a 1"

Phrase: ":"

Phrase: "1 slurry of protein A-Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883043:Slurry [Substance]

Phrase: "beads for 4h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0991566:Beads [Biomedical or Dental Material]
   790   C1292426:4H [Temporal Concept]
   790   C2346972:Bead [Spatial Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.52: The immune complexes were collected by centrifugation and washed five times with a buffer (20mM Tris, pH 7.5,1mM EDTA, 1mM EGTA, 150mM NaCl, 2mM Na3VO4, 10% glycerol, and 1% Nonidet P-40) and resuspended in sample buffer. 

Phrase: "The immune complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439662:Immune [Functional Concept]
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "washed five times with a buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "(20mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "2mM Na3VO4,"

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "resuspended in sample buffer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.53: Immune complexes were subjected to SDS-PAGE and Western blot analysis using the indicated antibody. 

Phrase: "Immune complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439662:Immune [Functional Concept]
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the indicated antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.54: The protein bands were visualized using ECL (Amersham Biosciences). 

Phrase: "The protein bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ECL (Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.55: Construction and Preparation of GST Fusion Proteins-- The full-length cDNA of human PLD1 or PLD2 was digested into fragments containing specific domains. 

Phrase: "Construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Preparation of GST Fusion Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The full-length cDNA of human PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "was"

Phrase: "digested into fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332255:fragments [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C0868946:digested [Physiologic Function]
   756 E C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "specific domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.56: These individual PLD1 or PLD2 fragments were then ligated into the EcoRI or SmaI site of the pGEX4T1 vector. 

Phrase: "These individual PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "PLD2 fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
   734   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "ligated into the EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "SmaI site of the pGEX4T1 vector."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.57: Subcloning and the polymerase chain reaction (PCR) were used to produce the expression vectors encoding the respective GST fusion proteins. 

Phrase: "Subcloning"

Phrase: "and"

Phrase: "the polymerase chain reaction (PCR)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "the expression vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the respective GST fusion proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.58: Escherichia coli BL21 cells were transformed with individual expression vectors encoding the GST fusion proteins, and after harvesting the cells, the GST fusion protein expressed were purified by standard methods (29) using glutathione-Sepharose 4B (Amersham Biosciences). 

Phrase: "Escherichia coli BL21 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transformed with individual expression vectors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0027361:Individual [Population Group]
   760   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0237401:Individual [Human]
   760   C0442335:Vectors [Spatial Concept]
   760   C1510411:Transformed [Pathologic Function]
   726 E C1705099:Vector [Idea or Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the GST fusion proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "after"

Phrase: "harvesting"

Phrase: "the cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "the GST fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "expressed"

Phrase: "were"

Phrase: "purified by standard methods"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C1998793:Purified [Functional Concept]
   770   C2828392:Standard [Intellectual Product]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "(29"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "glutathione-Sepharose 4B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036682:Sepharose 4B [Biomedical or Dental Material,Carbohydrate]
   827   C0450375:4b [Intellectual Product]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.59: Preparation of Rat Brain Extract-- Rat brain (2g) was homogenized in lysis buffer using a polytron homogenizer. 

Phrase: "Preparation of Rat Brain Extract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "--"

Phrase: "Rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(2g"

Phrase: ")"

Phrase: "was"

Phrase: "homogenized in lysis buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a polytron homogenizer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.60: After centrifugation at 100,000g for 1h at 4C, the resulting supernatant was used to investigate potential -synuclein or PLD binding domains. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 100,"

Phrase: "000g for 1h"

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the resulting supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "potential -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "PLD binding domains."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]
   708   C1523907:phospholipase binding [Molecular Function]
Processing 00000000.tx.61: Protein concentrations were determined using the methods developed by Bradford (30). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "developed by Bradford"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.62: In Vitro Binding Experiment-- Clarified lysates (1mg) of rat brain were incubated with 3g of GST fusion proteins immobilized on glutathione-Sepharose beads in a final volume of 500l of lysis buffer for 1.5h at 4C. 

Phrase: "In Vitro Binding Experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0681814:Experiment [Research Activity]
   812   C1706386:Experiment [Conceptual Entity]
   741 E C1517586:Experimental [Qualitative Concept]

Phrase: "--"

Phrase: "Clarified lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "(1mg"

Phrase: ")"

Phrase: "of rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "incubated with 3g of GST fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332466:Fusion [Functional Concept]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   748   C1439852:Incubated [Laboratory Procedure]
   745   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "immobilized on glutathione-Sepharose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0036681:Sepharose [Carbohydrate]

Phrase: "beads in a final volume of 500l of lysis buffer"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0024348:Lysis [Pathologic Function]
   739   C0205088:Final [Temporal Concept]
   739   C0449468:*Volume [Quantitative Concept]
   739   C0991566:Beads [Biomedical or Dental Material]
   739   C1536403:lysis [Cell Function]
   739   C1546485:Final [Idea or Concept]
   739   C1690016:% volume [Qualitative Concept]
   739   C1705102:Volume [Intellectual Product]
   739   C2346972:Bead [Spatial Concept]
   739   C2700258:Volume [Laboratory Procedure]

Phrase: "for 1.5h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979835:1.5H [Temporal Concept]
   861   C1442467:5H [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.63: Protein complexes were collected by centrifugation and washed four times with washing buffer (1% Triton X-100, 150mM NaCl, 20mM Tris-HCl, pH 8.0,20mM NaF, 2mM sodium orthovanadate, 1mM PMSF, 10g/ml leupeptin, 10g/ml aprotinin). 

Phrase: "Protein complexes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1523872:protein complex [Cell Component]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "washed four times with washing buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "(1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "20mM Tris-HCl,"

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "20mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   861   C1366571:NAF [Gene or Genome]
   861   C1705592:NAF [Gene or Genome]

Phrase: "2mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0029366:Orthovanadate [Inorganic Chemical]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "1mM PMSF,"

Phrase: "10g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "10g/ml aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.64: Associated protein complexes were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. 

Phrase: "Associated protein complexes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "transferred to a nitrocellulose membrane."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
Processing 00000000.tx.65: Immunoreactivity was detected using the indicated antibodies, horseradish peroxidase-conjugated secondary antibodies, and ECL according to the manufacturer's instructions. 

Phrase: "Immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the indicated antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "horseradish peroxidase-conjugated secondary antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "ECL according to the manufacturer's instructions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1332684:ECL [Gene or Genome]
Processing 00000000.tx.66: Measurement of Phosphoinositides Hydrolysis by PLC-- Cells were plated into 60-mm dishes at 5105 cells per dish and grown for 1day. 

Phrase: "Measurement of Phosphoinositides Hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "by PLC-- Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated into 60-mm dishes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C0005971:Plate [Medical Device]
   726   C0020498:DISH [Disease or Syndrome]
   726   C1139930:plate [Medical Device]
   726   C3537155:Plate [Manufactured Object]

Phrase: "at 5105 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "per dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "grown for 1day."
Processing 00000000.tx.67: The cells were then labeled with myo-[2-3H]inositol (2Ci/ml) in inositol-free DMEM for 20h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "labeled with myo-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[2-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]inositol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]

Phrase: "(2Ci/ml) in inositol-free DMEM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "for 20h."
Processing 00000000.tx.68: Subsequently, the labeled cells were washed and pretreated with 20mM LiCl for 15min in DMEM containing 20mM Hepes, pH 7.2,and 1mg/ml bovine serum albumin. 

Phrase: "Subsequently,"

Phrase: "the labeled cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "pretreated with 20mM LiCl"

Phrase: "for 15min"

Phrase: "in DMEM containing 20mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "1mg/ml bovine serum albumin."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
Processing 00000000.tx.69: Stimulation was initiated by the addition of pervanadate for 50min and terminated by the addition of ice-cold 5% HClO4. 

Phrase: "Stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "initiated by the addition of pervanadate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
   753   C1883712:Addition [Functional Concept]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "for 50min"

Phrase: "and"

Phrase: "terminated by the addition of ice-cold 5% HClO4."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0456963:Ice cold [Qualitative Concept]
   742   C0009264:Cold [Natural Phenomenon or Process]
   742   C0009443:Cold [Disease or Syndrome]
   742   C0020746:Ice [Inorganic Chemical]
   742   C0234192:Cold [Physiologic Function]
   742   C1553404:terminated [Idea or Concept]
   742   C1883712:Addition [Functional Concept]
   742   C2348570:Terminated [Functional Concept]
Processing 00000000.tx.70: After 30min in an ice bath, extracts were centrifuged, diluted with distilled water, and applied to Bio-Rad Dowex AG 1-X8 anion exchanger column. 

Phrase: "After 30min"

Phrase: "in an ice bath,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150141:Bath [Therapeutic or Preventive Procedure]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: ","

Phrase: "diluted with distilled water,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "applied to Bio-Rad Dowex AG 1-X8 anion exchanger column."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   772   C0242194:Anion Exchanger 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0003075:Anion [Element, Ion, or Isotope]
   738   C0058714:Dowex [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   738   C0185125:Applied [Health Care Activity]
   738   C1185738:Column [Body Part, Organ, or Organ Component]
   738   C1621574:exchanger [Molecular Function]
   738   C1706132:Column [Idea or Concept]
   704 E C1632850:Apply [Functional Concept]
   704 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.71: The column was then washed with 10ml of distilled water followed by 10ml of 60mM ammonium formate containing 5mM of sodium tetraborate. 

Phrase: "The column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with 10ml of distilled water"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0599638:WATER [Substance]
   753   C0681549:distilled [Occupational Activity]
   753   C1548982:Washed [Idea or Concept]
   753   C1550678:Water [Inorganic Chemical]
   719 E C0441648:Wash [Activity]

Phrase: "followed by 10ml of 60mM ammonium formate containing 5mM of sodium tetraborate."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   753   C0074727:Sodium tetraborate [Inorganic Chemical,Pharmacologic Substance]
   753   C0103071:ammonium formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0332283:Followed by [Temporal Concept]
           followed
   753   C3541316:Sodium Tetraborate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   751   C0142851:sodium formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   736   C0002611:Ammonium [Inorganic Chemical]
   736   C0016572:formate [Organic Chemical]
   736   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   736   C0076219:tetraborate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   736   C0220832:formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   736   C0332256:Containing [Functional Concept]
   736   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   736   C2700400:Containing [Activity]
   703 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.72: Total inositol phosphates were eluted with a solution containing 1M ammonium formate and 0.1M formic acid. 

Phrase: "Total inositol phosphates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0021554:Inositol Phosphates [Carbohydrate]
   827   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   827   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   793 E C0031701:phosphate [Organophosphorus Compound]
   793 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "eluted with a solution containing 1M ammonium formate"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0103071:ammonium formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0002611:Ammonium [Inorganic Chemical]
   744   C0016572:formate [Organic Chemical]
   744   C0037633:Solution [Substance]
   744   C0220832:formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0332256:Containing [Functional Concept]
   744   C0470296:1M [Quantitative Concept]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "0.1M formic acid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0885348:formic acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.73: Phospholipase D Assay-- PLD activity was assessed by measuring the formation of [3H]phosphatidylbutanol, the product of transphosphatidylation in the presence of 1-butanol. 

Phrase: "Phospholipase D Assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "--"

Phrase: "PLD activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149851:phospholipase D activity [Molecular Function]
   913   C1149838:phospholipase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "assessed by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   790   C1516048:Assessed [Activity]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the formation of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]phosphatidylbutanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136784:phosphatidylbutanol [Lipid]

Phrase: "the product of transphosphatidylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514468:product [Entity]
   770   C1704444:Product [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1-butanol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0089147:1-Butanol [Lipid]
           butanol
   861   C0001977:Butanol [Lipid]
Processing 00000000.tx.74: HEK 293cells were subcultured in six-well plates at 2105 cells/well. 

Phrase: "HEK 293cells"

Phrase: "were"

Phrase: "subcultured in six-well"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205170:Well [Qualitative Concept]
   770   C0205452:Six [Quantitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0200940:Subculture [Laboratory Procedure]
   737   C0699799:subculture [Population Group]

Phrase: "plates at 2105 cells/well."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C2347578:Cells/well [Quantitative Concept]
   797   C1166718:cells plate [Cell Component]
   760   C0005971:Plate [Medical Device]
   760   C0007634:Cells [Cell]
   760   C0205170:Well [Qualitative Concept]
   760   C1139930:plate [Medical Device]
   760   C3146287:Well [Manufactured Object]
   760   C3282337:Cells [Cell]
   760   C3537155:Plate [Manufactured Object]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.75: The cells were serum-starved in DMEM for 24h before the start of the assay. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved in DMEM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2348531:Starve [Activity]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "before the start"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "of the assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.76: For the final 20h of serum starvation, the cells were labeled with 1Ci/ml [9,10-3H]myristic acid. 

Phrase: "For the final 20h"

Phrase: "of serum starvation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038187:Starvation [Finding]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled with 1Ci/ml [9,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0066653:ML 9 [Organic Chemical]
   760   C0439526:/mL [Quantitative Concept]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "10-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]myristic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027138:Myristic Acid [Biologically Active Substance,Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.77: The cells were washed three times with 5ml of phosphate-buffered saline (PBS) and pre-equilibrated in serum-free DMEM for 1h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with 5ml of phosphate-buffered saline (PBS)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0040223:times [Temporal Concept]
   744   C1632851:Times [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "pre-equilibrated in serum-free DMEM"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0229671:Serum [Body Substance]
   753   C0332152:Pre [Temporal Concept]
   753   C0332296:free [Functional Concept]
   753   C0740175:Pre [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2257086:PRE [Genetic Function]

Phrase: "for 1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.78: For the final 10min of preincubation, 0.3% butan-1-ol was included. 

Phrase: "For the final 10min"

Phrase: "of preincubation,"

Phrase: "0.3% butan-1-ol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C0089147:Butan-1-ol [Lipid]

Phrase: "was"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.79: At the end of the preincubation, cells were treated with pervanadate or PMA for the indicated times. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the preincubation,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with pervanadate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "PMA for the indicated times."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C2825188:PMA [Intellectual Product]
Processing 00000000.tx.80: Incubations were terminated by removing the medium, washing with 5ml of ice-cold PBS, and adding 1ml of ice-cold methanol. 

Phrase: "Incubations"

Phrase: "were"

Phrase: "terminated by removing"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C1553404:terminated [Idea or Concept]
   790   C2348570:Terminated [Functional Concept]
   756   C0849355:remove [Qualitative Concept]
   756   C1883720:Remove [Activity]
   756   C3244314:remove [Functional Concept]
   718 E C0011065:Expired [Organism Function]
   718 E C0231800:Expired [Organ or Tissue Function]
   718 E C1704631:Expire [Idea or Concept]

Phrase: "the medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "washing with 5ml of ice-cold PBS,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0456963:Ice cold [Qualitative Concept]
   762   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0009264:Cold [Natural Phenomenon or Process]
   742   C0009443:Cold [Disease or Syndrome]
   742   C0020746:Ice [Inorganic Chemical]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C0036082:Saline [Substance]
   742   C0234192:Cold [Physiologic Function]
   742   C0441648:Washing [Activity]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "adding 1ml of ice-cold methanol."
Processing 00000000.tx.81: Cells were scraped off the plates using a policeman, and the lipids were extracted and separated with methanol/chloroform/0.1 N HCl (1:1:1) according to the method of Bligh and Dyer (31). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "scraped off the plates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0184933:scraped [Therapeutic or Preventive Procedure]
   770   C0444082:scraped [Body Substance]
   770   C1139930:plates [Medical Device]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a policeman,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086825:Policeman [Professional or Occupational Group]

Phrase: "and"

Phrase: "the lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "separated with methanol/chloroform/0.1 N HCl (1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   742   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0086972:Separated [Finding]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "according to the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Bligh"

Phrase: "and"

Phrase: "Dyer"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: The lower phase was dried under N2, resuspended in 30l of chloroform/methanol (2:1), and spotted onto silica gel 60A thin layer chromatography plate (Whatman). 

Phrase: "The lower phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "dried under N2,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0441960:N2 [Finding]
   790   C1512080:Dried [Qualitative Concept]
   790   C2827485:Dried [Body Substance]
   756 E C0011682:Dry [Natural Phenomenon or Process]
   756 E C0205222:Dry [Qualitative Concept]

Phrase: "resuspended in 30l of chloroform/methanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "spotted onto silica gel 60A thin layer chromatography plate"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   790   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   764   C2936385:Silica Gel [Biomedical or Dental Material,Inorganic Chemical]
   762   C0008559:Gel Chromatography [Laboratory Procedure]
   742   C0005971:Plate [Medical Device]
   742   C0008550:Chromatography [Laboratory Procedure]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0037098:Silica [Biomedical or Dental Material,Inorganic Chemical]
   742   C0205168:Thin [Qualitative Concept]
   742   C0934502:Layer [Body Part, Organ, or Organ Component]
   742   C1139930:plate [Medical Device]
   742   C1382104:Gel [Substance]
   742   C1522408:Layer [Qualitative Concept]
   742   C1561599:Layer [Intellectual Product]
   742   C3537155:Plate [Manufactured Object]
   708   C0329155:Spot [Fish]
   708   C1427618:SPOT [Gene or Genome]
   708   C1705203:Spot [Conceptual Entity]

Phrase: "(Whatman"

Phrase: ")."
Processing 00000000.tx.83: The plates were developed in the upper phase of the solvent system of ethyl acetate/iso-octane/H2O/acetic acid (55:25:50:10) and stained with iodine. 

Phrase: "The plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "developed in the upper phase of the solvent system"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]
   742   C0205390:Phase [Temporal Concept]
   742   C0449913:System [Functional Concept]
   742   C1282910:Upper [Spatial Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]

Phrase: "of ethyl acetate/iso-octane/H2O/acetic acid"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   818   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   818   C0000985:Acetic acid [Organic Chemical]
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]
   795   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   740 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "25"

Phrase: ":"

Phrase: "50"

Phrase: ":"

Phrase: "10"

Phrase: ")"

Phrase: "and"

Phrase: "stained with iodine."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   841   C2827828:IODINE STAIN [Laboratory Procedure]
   790   C0021966:Iodine- [Inorganic Chemical]
   790   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C0885449:iodine [Pharmacologic Substance]
   790   C2348268:Iodine [Element, Ion, or Isotope]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.84: A phosphatidylbutanol standard (Avanti Polar Lipids) was used to locate the bands, which were scraped into scintillation mixture. 

Phrase: "A phosphatidylbutanol standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "(Avanti Polar Lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023779:Lipids [Lipid]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "locate"

Phrase: "the bands,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "which"

Phrase: "were"

Phrase: "scraped into scintillation mixture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0184933:scraped [Therapeutic or Preventive Procedure]
   770   C0439962:Mixture [Substance]
   770   C0444082:scraped [Body Substance]
   770   C0678573:scintillation [Natural Phenomenon or Process]
Processing 00000000.tx.85: Radioactivity incorporated into total phospholipids was measured, and the results were presented as percentage of total lipid counts/min incorporated into phosphatidylbutanol to normalize the results. 

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "incorporated into total phospholipids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   737 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "presented as percentage of total lipid"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0369610:total lipid [Finding]
   753   C0023779:Lipid [Lipid]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "counts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439157:counts [Quantitative Concept]
  1000   C0750480:Count [Activity]
  1000   C1705566:Count [Quantitative Concept]

Phrase: "/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "incorporated into phosphatidylbutanol to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0136784:phosphatidylbutanol [Lipid]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "the results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.86: Immunofluorescent Staining-- To examine the co-localization of -synuclein with PLD1, a double-immunofluorescence technique was used. 

Phrase: "Immunofluorescent Staining"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   983   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
           Immunofluorescent
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   789 E C0016318:Immunofluorescence [Laboratory Procedure]
   789 E C0079603:Immunofluorescence [Laboratory Procedure]
   768 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the co-localization of -synuclein with PLD1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a double-immunofluorescence technique"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0016318:Immunofluorescence Technique [Laboratory Procedure]
           Immunofluorescence
   873 E C0282649:Immunofluorescence Technique, Direct [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   827   C0449851:Technique [Functional Concept]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
   743 E C0025664:techniques [Intellectual Product]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.87: Three male Sprague-Dawley rats (3-6 months old) were deeply anesthetized with 4% chloral hydrate (1ml/100 mg) and were sacrificed by transcardial perfusion with a fixative containing 4% paraformaldehyde in 0.1M phosphate buffer, pH 7.4.

Phrase: "Three male Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0034715:Rats, Sprague-Dawley [Mammal]
   840   C2699239:Sprague-Dawley [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "(3-6 months"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1442461:3 Months [Temporal Concept]
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]
   734   C0442759:3 6 [Finding]

Phrase: "old)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580836:Old [Temporal Concept]

Phrase: "were"

Phrase: "deeply"

Phrase: "anesthetized with 4% chloral hydrate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0008161:Chloral Hydrate [Organic Chemical,Pharmacologic Substance]
   760   C0077034:Chloral [Organic Chemical,Pharmacologic Substance]
   760   C0720930:hydrate [Organic Chemical,Pharmacologic Substance]
   760   C1720436:Anesthetized [Finding]
   751 E C0699293:Noctec [Organic Chemical,Pharmacologic Substance]

Phrase: "(1ml/100 mg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "were"

Phrase: "sacrificed by transcardial perfusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031001:Perfusion [Therapeutic or Preventive Procedure]
   737   C0681205:Sacrifice [Idea or Concept]

Phrase: "with a fixative containing 4% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "in 0.1M phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.88: Cryostat coronal sections (25m thick) were cut throughout the mesencephalon and were processed for double-immunofluorescence histochemistry. 

Phrase: "Cryostat coronal sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205123:Coronal [Spatial Concept]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "(25m"

Phrase: "thick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "cut throughout the mesencephalon"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0000925:Cut [Injury or Poisoning]
   770   C0025462:Mesencephalon [Body Part, Organ, or Organ Component]
   770   C1883724:CUT [Phenomenon or Process]
   715 E C1280997:Midbrain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "were"

Phrase: "processed for double-immunofluorescence histochemistry."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0016318:Immunofluorescence [Laboratory Procedure]
   760   C0019635:Histochemistry [Laboratory Procedure]
   760   C0079603:Immunofluorescence [Laboratory Procedure]
   760   C0205173:Double [Functional Concept]
   760   C1522240:Processed [Phenomenon or Process]
   760   C1705764:Double [Activity]
   760   C1705765:Double [Qualitative Concept]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]
   704 E C0282648:Direct immunofluorescence [Laboratory Procedure]
Processing 00000000.tx.89: Free floating sections were blocked in 10% normal donkey serum and normal goat serum in 0.01M PBS for 1h. 

Phrase: "Free floating sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]
   734   C0443223:Free-floating [Qualitative Concept]

Phrase: "were"

Phrase: "blocked in 10% normal donkey serum"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   753   C0028778:Blocked [Pathologic Function]
   753   C0205307:Normal [Qualitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0324145:Donkey [Mammal]
   753   C0332206:Blocked [Functional Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "normal goat serum in 0.01M PBS"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   781   C0858153:Normal serum phosphate [Finding]
   762   C0036820:phosphate serum [Laboratory Procedure]
   762   C0445115:Normal saline [Inorganic Chemical,Pharmacologic Substance]
   742   C0018019:goat [Mammal]
   742   C0205307:Normal [Qualitative Concept]
   742   C0229671:Serum [Body Substance]
   742   C0439166:% normal [Quantitative Concept]
   742   C1265549:goat [Mammal]
   742   C1510458:Goat [Mammal]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C2347086:% Normal [Quantitative Concept]

Phrase: "for 1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.90: Incubation with primary antibodies was performed with a mouse monoclonal antibody against -synuclein and an affinity-purified anti-PLD1 antibody overnight at 4C. 

Phrase: "Incubation with primary antibodies"

Phrase: "was"

Phrase: "performed with a mouse monoclonal antibody"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0746619:monoclonal [Finding]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "against -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "an affinity-purified anti-PLD1 antibody overnight at 4C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0003255:Antibody Affinity [Molecular Function]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.91: After washing in PBS, the sections were incubated with a mixture of fluorescein isothiocyanate-conjugated goat anti-mouse IgG (Jackson ImmunoResearch; 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "in PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with a mixture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439962:Mixture [Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "of fluorescein isothiocyanate-conjugated goat anti-mouse IgG (Jackson ImmunoResearch"

Phrase: ";"
Processing 00000000.tx.92: diluted at 1:100) and Cy3-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch; 

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "and"

Phrase: "Cy3-conjugated goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0034493:Rabbit [Mammal]

Phrase: "(Jackson ImmunoResearch"

Phrase: ";"
Processing 00000000.tx.93: diluted at 1:100) for 2h at room temperature. 

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.94: To test the specificity of immunostaining, control sections were processed in an identical manner but with the primary or secondary antibodies omitted. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the specificity of immunostaining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "control sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "processed in an identical manner"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205280:Identical [Qualitative Concept]
   760   C1522240:Processed [Phenomenon or Process]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "but with the primary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205225:Primary [Qualitative Concept]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "omitted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]
Processing 00000000.tx.95: Slides were viewed using a confocal microscope (MRC-1024, Bio-Rad). 

Phrase: "Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "viewed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449911:View [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a confocal microscope"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1626420:Confocal microscope [Medical Device]
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "(MRC-1024,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1540289:MRC [Gene or Genome]
   861   C2698590:MRC [Gene or Genome]

Phrase: "Bio-Rad"

Phrase: ")."
Processing 00000000.tx.96: Images were converted to TIFF format, and contrast levels of images were adjusted using Adobe Photoshop. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "converted to TIFF format,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1301627:Format [Intellectual Product]
   770   C2348636:TIFF [Functional Concept]

Phrase: "and"

Phrase: "contrast levels of images"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Adobe Photoshop."
Processing 00000000.tx.97: Formation of Eosinophilic Inclusions-- We performed hematoxylin and eosin (H&E) staining according to standard cell biology techniques (16, 32). 

Phrase: "Formation of Eosinophilic Inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "hematoxylin and eosin (H&E) staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "according to standard cell biology techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0025664:techniques [Intellectual Product]
   812   C0449851:Techniques [Functional Concept]

Phrase: "(16,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.98: At 30h post-transfection, the co-transfected HEK 293cells were fixed with 3.7% formaldehyde-PBS buffer for 15min at room temperature and hydrated with distilled water for 10min. 

Phrase: "At 30h post-transfection,"

Phrase: "the"

Phrase: "co-transfected"

Phrase: "HEK 293cells"

Phrase: "were"

Phrase: "fixed with 3.7% formaldehyde-PBS buffer"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   784   C1298529:Formaldehyde 3.7% [Clinical Drug]
   762   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C0036082:Saline [Substance]
   742   C0231441:Fixed [Finding]
   742   C0443218:Fixed [Qualitative Concept]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   742   C2827483:Fixed [Body Substance]

Phrase: "for 15min"

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "hydrated with distilled water"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C0720930:hydrated [Organic Chemical,Pharmacologic Substance]
   770   C1550678:Water [Inorganic Chemical]

Phrase: "for 10min."
Processing 00000000.tx.99: The hydrated cells were stained with Mayer's hematoxylin solution (Sigma) for 5min and washed in distilled water. 

Phrase: "The hydrated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with Mayer's hematoxylin solution"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0491949:HEMATOXYLIN MAYER'S [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   781   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "for 5min"

Phrase: "and"

Phrase: "washed in distilled water."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1548982:Washed [Idea or Concept]
   770   C1550678:Water [Inorganic Chemical]
   737 E C0441648:Wash [Activity]
Processing 00000000.tx.100: Cells were destained with 1% HCl in ethanol for 30s and neutralized with 0.2% ammonia for 30s. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "destained with 1% HCl"

Phrase: "in ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001962:Ethanol [Organic Chemical]

Phrase: "for 30s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227073:30S [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "neutralized with 0.2% ammonia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002607:Ammonia [Inorganic Chemical,Pharmacologic Substance]
   760   C1095824:Ammonia [Eukaryote]

Phrase: "for 30s."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227073:30S [Body Part, Organ, or Organ Component]
Processing 00000000.tx.101: The processed cells were stained with eosin solution (Eosin Y, 0.5% aqueous solution, Sigma) for 1min, followed by washing in distilled water. 

Phrase: "The processed cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with eosin solution"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Eosin Y,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014448:Eosin Y [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Eosin
   861   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: "0.5% aqueous solution,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C3255993:aqueous solution [Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
   812   C0599956:Aqueous [Qualitative Concept]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "for 1min,"

Phrase: "followed by washing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0441648:Washing [Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in distilled water."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C0681549:distilled [Occupational Activity]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.102: The cells were dehydrated by rinsing in the following concentration series of ethanol, 70,80,and 100%, at room temperature and then mounted with 100% glycerol. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "dehydrated by rinsing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011175:Dehydrated [Disease or Syndrome]
   790   C1882955:Rinsing [Activity]

Phrase: "in the following concentration series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "of ethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001962:Ethanol [Organic Chemical]

Phrase: "70,"

Phrase: "80,"

Phrase: "and"

Phrase: "100%,"

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "mounted with 100% glycerol."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0449878:mounted [Finding]
   737 E C0181909:Mount [Medical Device]
Processing 00000000.tx.103: All cells were counted in fields chosen at random from five different circles of the cell culture well (all cells were counted in five randomly selected fields under a light microscope at a magnification of 400). 

Phrase: "All cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted in fields"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   756   C0750480:Count [Activity]
   756   C1521738:Field [Conceptual Entity]
   756   C1705566:Count [Quantitative Concept]
   756   C2346620:Field [Conceptual Entity]
   756   C2349184:Field [Conceptual Entity]
   756   C3539073:FIELD [Spatial Concept]

Phrase: "chosen at random"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034656:RANDOM [Research Activity]
   790   C0439605:Random [Qualitative Concept]
   790   C1707391:Chosen [Activity]

Phrase: "from five different circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1282913:Circle [Spatial Concept]
   793   C1551714:Circle [Population Group]

Phrase: "of the cell culture well"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "("

Phrase: "all cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted in five randomly selected fields"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205451:Five [Quantitative Concept]
   719   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   719   C0750480:Count [Activity]
   719   C1521738:Field [Conceptual Entity]
   719   C1705566:Count [Quantitative Concept]
   719   C1707391:Select [Activity]
   719   C2346620:Field [Conceptual Entity]
   719   C2349184:Field [Conceptual Entity]
   719   C3539073:FIELD [Spatial Concept]

Phrase: "under a light microscope"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0491970:Light Microscope [Medical Device]
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0181839:Microscope [Medical Device]
   861   C1306462:Light [Functional Concept]
   861   C1706379:Microscope [Medical Device]
   861   C1881376:Light [Qualitative Concept]

Phrase: "at a magnification"

Phrase: "of 400"

Phrase: ")."
Processing 00000000.tx.104: Values are expressed as percentages of cells containing eosinophilic protein aggregates with pinkish color relative to total cells. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as percentages of cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726   C0439165:Percentage [Quantitative Concept]
   726 E C1269647:Cell [Cell]
   726   C1549488:Percentage [Idea or Concept]
   726   C1561533:Percentage [Idea or Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "eosinophilic protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aggregates with pinkish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205418:Aggregate [Qualitative Concept]

Phrase: "color"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009393:Color [Natural Phenomenon or Process]
  1000   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
  1000   C1705245:Color [Pharmacologic Substance]

Phrase: "relative to total cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.105: Error bars shown in this study represent S.D. derived from means for three independent replicates. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "shown in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C1547282:Show [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "derived from means"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C1441547:Derived [Qualitative Concept]
   790   C1704970:Means [Conceptual Entity]
   790   C3245521:derived [Idea or Concept]
   756 E C0444504:Mean [Quantitative Concept]
   756 E C2347634:Mean [Quantitative Concept]
   756 E C2348143:Mean [Quantitative Concept]

Phrase: "for three independent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085862:Independent [Idea or Concept]
   861   C1299583:Independent [Finding]

Phrase: "replicates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]
Processing 00000000.tx.106: Statistical Analysis-- Data are expressed as meansS.D. 

Phrase: "Statistical Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as meansS.D."
Processing 00000000.tx.107: The Student's t test was used where appropriate. 

Phrase: "The Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "where appropriate."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1548787:Appropriate [Qualitative Concept]
   789 E C0814634:appropriateness [Qualitative Concept]
Processing 00000000.tx.108: A probability of p<0.05was considered statistically significant.  

Phrase: "A probability of p<0.05was"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033204:Probability [Quantitative Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.109: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein Inhibits Pervanadate or PMA-induced PLD Activity in HEK 293Cells-- To investigate whether -synuclein might affect PLD activity in human cell lines, we generated a line of 293HEK cells overexpressing wild-type (wt), A30P, or A53T -synuclein, as well as a vector transfected control cell line (Vec). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "PMA-induced PLD Activity in HEK 293Cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   782   C1149851:phospholipase D activity [Molecular Function]
   757   C0020115:Human Activity [Activity]
   757   C1149838:phospholipase activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "PLD activity in human cell lines,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C1149851:phospholipase D activity [Molecular Function]
   774   C0020115:Human Activity [Activity]
   774   C1149838:phospholipase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a line of 293HEK cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0007600:cells line [Cell]
   760   C0205132:Line [Spatial Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "wild-type (wt), A30P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2987124:PRO [Intellectual Product]

Phrase: "or"

Phrase: "A53T -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "a vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "transfected"

Phrase: "control cell line"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1550141:Control [Substance]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1882979:Control [Conceptual Entity]
   827   C1948049:Cell [Spatial Concept]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(Vec"

Phrase: ")."
Processing 00000000.tx.110: Pervanadate, a complex of vanadate and hydrogen peroxide, is a competitive inhibitor of protein-tyrosine phosphatase that works by irreversible oxidation and functions on intact cells because of its cell permeability (33). 

Phrase: "Pervanadate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "a complex of vanadate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "hydrogen peroxide,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "is"

Phrase: "a competitive inhibitor of protein-tyrosine phosphatase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1514560:Protein Phosphatase Inhibitor [Pharmacologic Substance]
   774   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "that works by irreversible oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043227:works [Occupational Activity]

Phrase: "and"

Phrase: "functions on intact cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   819   C0007613:cells function [Cell Function]
   816   C0682538:intact cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0031843:function [Physiologic Function]
   770   C0205266:Intact [Qualitative Concept]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1554187:Intact [Idea or Concept]
   770   C1705273:Function [Intellectual Product]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "because of its cell permeability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031164:Permeability [Natural Phenomenon or Process]
   789 E C0205326:Permeable [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.111: Pervanadate is also known to stimulate PLD activity (34-36). 

Phrase: "Pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "also"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "PLD activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149851:phospholipase D activity [Molecular Function]
   913   C1149838:phospholipase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(34-36"

Phrase: ")."
Processing 00000000.tx.112: Pervanadate stimulated PLD activity less in wild-type, A30P, or A53T -synuclein cell lines than in the control cell line (Fig. 1A). 

Phrase: "Pervanadate stimulated PLD activity less in wild-type, A30P,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1149851:phospholipase D activity [Molecular Function]
   754   C1149838:phospholipase activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "A53T -synuclein cell lines than"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "in the control cell line"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1550141:Control [Substance]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1882979:Control [Conceptual Entity]
   827   C1948049:Cell [Spatial Concept]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.113: Inhibition of pervanadate-stimulated PLD activity in -synuclein HEK 293cells occurred in a time dependent manner, compared with that of control cells (Fig. 1B). 

Phrase: "Inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of pervanadate-stimulated PLD activity in -synuclein HEK 293cells"

Phrase: "occurred in a time dependent manner,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0040223:Time [Temporal Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1709305:Occurred [Activity]
   753   C3244310:dependent [Functional Concept]
   753   C3541383:Time [Temporal Concept]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "compared with that of control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: We also examined an effect of -synuclein on another activator of PLD, PMA. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "an effect of -synuclein on another activator of PLD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PMA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]
Processing 00000000.tx.115: PMA-induced PLD activation in cells expressing -synuclein also was more reduced, compared with that of control cells (Fig. 1C). 

Phrase: "PMA-induced PLD activation in cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1326120:activation cells [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "expressing -"

Phrase: "synuclein also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "compared with that of control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.116: To examine the relative contribution of PLD protein to PLD activity in HEK cells, we investigated the expression level of PLD isozymes. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the relative contribution of PLD protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "to PLD activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149851:phospholipase D activity [Molecular Function]
   913   C1149838:phospholipase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in HEK cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the expression level of PLD isozymes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.117: By immunoprecipitation and Western blot analysis using anti-PLD antibody, cells overexpressing wild-type -synuclein or vector-transfected cell line were found to express similar levels of PLD1 (Fig. 2). 

Phrase: "By immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-PLD antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti D
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "vector-transfected cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "similar levels of PLD1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.118: However, PLD2 was not detected in either cells (data not shown). 

Phrase: "However,"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in either cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.119: Similar results were observed in HEK 293cells stably transfected with A30P or A53T (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed in HEK 293cells stably"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0013935:Embryonic [Embryonic Structure]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1441672:Observed [Functional Concept]
   748   C1514845:KIDNEY [Tissue]

Phrase: "transfected with A30P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2987124:PRO [Intellectual Product]

Phrase: "or"

Phrase: "A53T (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: To further demonstrate the inhibitory effect of -synuclein on the PLD activity, we transiently co-transfected -synuclein and PLD1 or PLD2 into HEK 293cells. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "demonstrate"

Phrase: "the inhibitory effect of -synuclein on the PLD activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we transiently"

Phrase: "co-transfected -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "PLD2 into HEK 293cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1739833:phospholipase D2, human [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   748   C1414052:D2 [Gene or Genome]
   748   C1415944:D2 [Gene or Genome]
Processing 00000000.tx.121: Transfected cells were labeled with [3H]myristic acid and then either left untreated or stimulated with pervanadate (100M sodium orthovanadate and 0.5mM H2O2). 

Phrase: "Transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]myristic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027138:Myristic Acid [Biologically Active Substance,Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "then either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "or"

Phrase: "stimulated with pervanadate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(100M sodium orthovanadate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0029366:Orthovanadate [Inorganic Chemical]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.5mM H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.122: Cells co-transfected with -synuclein and PLD1 or PLD2 showed less pervanadate-induced PLD activation than cells transfected with PLD and vector (Fig. 4). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "less pervanadate-induced PLD activation than cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1326120:activation cells [Cell Function]
   744   C1879547:Activation [Activity]

Phrase: "transfected with PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.123: These results demonstrate that -synuclein inhibits both PLD1 and PLD2 activation induced by pervanadate in mammalian cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "both PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "and"

Phrase: "PLD2 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1879547:Activation [Activity]
   734   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]

Phrase: "induced by pervanadate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.124: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.125: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.126: Overexpression of -synuclein inhibits pervanadate-induced PLD activation in cells. 

Phrase: "Overexpression of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "pervanadate-induced PLD activation in cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1326120:activation cells [Cell Function]
   748   C1879547:Activation [Activity]
Processing 00000000.tx.127: A, HEK 293cells expressing wild-type (wt), A30P, and A53T -synuclein as well as vector-transfected cells were cultured in six-well plates, labeled with [3H]myristate, and treated with pervanadate (100M Na3VO4 and 0.5mM H2O2) for 30min. 

Phrase: "A,"

Phrase: "HEK 293cells"

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(wt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A30P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2987124:PRO [Intellectual Product]

Phrase: "and"

Phrase: "A53T -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "vector-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in six-well"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205170:Well [Qualitative Concept]
   770   C0205452:Six [Quantitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: ","

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]myristate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "treated with pervanadate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(100M Na3VO4"

Phrase: "and"

Phrase: "0.5mM H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 30min."
Processing 00000000.tx.128: B, vector and -synuclein HEK 293cells were treated with pervanadate for different times. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "and -"

Phrase: "synuclein HEK 293cells"

Phrase: "were"

Phrase: "treated with pervanadate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for different times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.129: C, vector and -synuclein HEK 293cells were treated with PMA for 50min. 

Phrase: "C,"

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "and -"

Phrase: "synuclein HEK 293cells"

Phrase: "were"

Phrase: "treated with PMA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C2825188:PMA [Intellectual Product]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 50min."
Processing 00000000.tx.130: The radioactivity incorporated into phosphatidylbutanol was measured as described under "Experimental Procedures." 

Phrase: "The radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "incorporated into phosphatidylbutanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0136784:phosphatidylbutanol [Lipid]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.131: Results are the meansS.D of three independent experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meansS.D of three independent experiments."
Processing 00000000.tx.132: *, p<0.05compared with PMA-treated control cells. 

Phrase: "*,"

Phrase: "p<0.05compared with PMA-treated control cells."
Processing 00000000.tx.133: View larger version (38K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.134: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.135: Expression of PLD1 in HEK 293cells. 

Phrase: "Expression of PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HEK 293cells."
Processing 00000000.tx.136: Vector or -synuclein-expressing cells were lysed, and immunoprecipitates (IP) were prepared using anti-PLD or anti--synuclein (Syn) antibodies. 

Phrase: "Vector or -synuclein-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "immunoprecipitates (IP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-PLD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0140430:Anti D [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "anti"

Phrase: "--"

Phrase: "synuclein (Syn) antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.137: Immunoprecipitants were analyzed by SDS-polyacrylamide gel electrophoresis, followed by transfer of proteins to nitrocellulose membrane and Western blotting (Blot) with anti-PLD or -synuclein (Syn) antibodies. 

Phrase: "Immunoprecipitants"

Phrase: "were"

Phrase: "analyzed by SDS-polyacrylamide gel electrophoresis,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0936012:Analyzed [Research Activity]
   753   C1382104:Gel [Substance]

Phrase: "followed by transfer of proteins to nitrocellulose membrane"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0332283:Followed by [Temporal Concept]
           followed
   767   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0025255:Membrane [Tissue]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040671:Transfer [Mental Process]
   744   C0596901:Membrane [Cell Component]
   744   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   744   C1705822:Transfer [Activity]
   744   C1706182:Membrane [Manufactured Object]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "Western blotting (Blot) with anti-PLD or -synuclein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   754 E C0949466:Western Blot [Laboratory Procedure]
   744   C1705493:Western [Spatial Concept]

Phrase: "(Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.138: The results shown are representative of three separate experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three separate experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.139: -Synuclein Is Tyrosine-phosphorylated by Pervanadate in HEK 293Cells-- Protein-tyrosine phosphorylation plays a pivotal role for the functional properties of numorous proteins. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Is"

Phrase: "Tyrosine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phosphorylated by Pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "in HEK 293Cells"

Phrase: "--"

Phrase: "Protein-tyrosine phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   901   C1519726:Tyrosine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a pivotal role for the functional properties of numorous proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1705810:Functional Role [Conceptual Entity]
           Role
   739   C0035820:Role [Social Behavior]
Processing 00000000.tx.140: -Synuclein appears to contain four tyrosine residues, which are consensus sequences for tyrosine kinase-mediated phosphorylation. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "four tyrosine residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "consensus sequences for tyrosine kinase-mediated phosphorylation."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   778   C0079160:Sequences, Consensus [Nucleotide Sequence]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0376298:Consensus [Social Behavior]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.141: Recently, it was reported that -synuclein is tyrosine-phosphorylated by the Src family of protein-tyrosine kinases such as c-Src and Fyn (37). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "tyrosine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phosphorylated by the Src family of protein-tyrosine kinases"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   810   C0282625:Protein-Tyrosine Kinases, src [Amino Acid, Peptide, or Protein,Enzyme]
           src-Family Tyrosine Kinases
           src Tyrosine Kinases
           src-Family Kinases
           src Kinases
   790   C0033681:Protein-Tyrosine Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           kinases tyrosine
   762   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
           Kinases
   742   C0015576:Family [Family Group]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C1704727:Family [Conceptual Entity]

Phrase: "such as c-Src"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079073:c src [Gene or Genome]
  1000   C0080298:c-src [Gene or Genome]
  1000   C0138965:c src [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Fyn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812303:FYN [Gene or Genome]
  1000   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.142: We investigated tyrosine phosphorylation of -synuclein in transfected cells. 

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "tyrosine phosphorylation of -synuclein in transfected cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.143: Immunoprecipitated -synuclein from either pervanadate-treated stably transfected HEK 293cells expressing human -synuclein was separated by SDS-PAGE in duplicate. 

Phrase: "Immunoprecipitated -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "synuclein from either pervanadate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "stably transfected HEK 293cells"

Phrase: "expressing"

Phrase: "human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "in duplicate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205173:Duplicate [Functional Concept]
  1000   C3539942:Duplicate [Intellectual Product]
Processing 00000000.tx.144: Western blot analysis was then performed with phosphotyrosine specific antibody (4G10), or -synuclein antibody, which specifically recognizes -synuclein (Fig. 3). 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "performed with phosphotyrosine specific antibody"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205369:Specific [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(4G10"

Phrase: ")"

Phrase: ","

Phrase: "or -synuclein antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which specifically"

Phrase: "recognizes -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.145: The cell lysates were also immunoprecipitated with anti-phosphotyrosine antibody and then analyzed by immunoblotting with anti--synuclein antibody. 

Phrase: "The cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "also"

Phrase: "immunoprecipitated with anti-phosphotyrosine antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with anti"

Phrase: "--"

Phrase: "synuclein antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.146: Pervanadate (100M sodium orthovanadate and 0.5mM H2O2) induced tyrosine phosphorylation of -synuclein. 

Phrase: "Pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(100M sodium orthovanadate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0029366:Orthovanadate [Inorganic Chemical]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.5mM H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "induced tyrosine phosphorylation of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.147: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.148: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.149: Pervanadate-induced tyrosine phosphorylation of -synuclein in cells. 

Phrase: "Pervanadate-induced tyrosine phosphorylation of -synuclein in cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.150: HEK cells overexpressing wild-type -synuclein were treated with pervanadate (PV) (100M Na3VO4 and 0.5mM H2O2) for 20min. 

Phrase: "HEK cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "treated with pervanadate (PV)"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(100M Na3VO4"

Phrase: "and"

Phrase: "0.5mM H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 20min."
Processing 00000000.tx.151: Cells were immunoprecipitated with anti--synuclein or anti-Tyr(P) antibody. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "immunoprecipitated with anti"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "--"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "anti-Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "(P) antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369773:P Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.152: Resulting immunoprecipitants were separated in duplicates by SDS-PAGE and transferred to nitrocellulose membranes using anti-Tyr(P) or -synuclein (Syn) antibodies. 

Phrase: "Resulting immunoprecipitants"

Phrase: "were"

Phrase: "separated in duplicates"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0086972:Separated [Finding]
   790   C0205173:duplicates [Functional Concept]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   756 E C3539942:Duplicate [Intellectual Product]

Phrase: "by SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "(P) or -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.153: The results shown are representative of three separate experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three separate experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.154: Effect of Tyrosine Phosphorylation State of -Synuclein on Pervanadate-induced PLD Activation-- We investigated the effect of the tyrosine phosphorylation state of -synuclein on pervanadate-induced PLD activity by mutating each of the tyrosines in -synuclein. 

Phrase: "Effect of Tyrosine Phosphorylation State of -Synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on Pervanadate-induced PLD Activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "-"

Phrase: "-"

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of the tyrosine phosphorylation state of -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on pervanadate-induced PLD activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C1149851:phospholipase D activity [Molecular Function]
   853   C1149838:phospholipase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "by mutating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1513776:Mutate [Genetic Function]

Phrase: "each of the tyrosines in -synuclein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1457900:Each [Quantitative Concept]
   719   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.155: Mutation of Tyr125 to Phe was the only tyrosine mutation to alter the activity of -synuclein. 

Phrase: "Mutation of Tyr125"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to Phe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phe [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "the only tyrosine mutation to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the activity of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.156: This reduced tyrosine phosphorylation to ~5% of the wild-type control, whereas other single amino acid changes do not change tyrosine phosphorylation significantly. 

Phrase: "This reduced tyrosine phosphorylation to ~5%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1519726:Tyrosine Phosphorylation [Molecular Function]
   804   C0031715:Phosphorylation [Molecular Function]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0392756:Reduced [Qualitative Concept]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "of the wild-type control,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "whereas"

Phrase: "other single amino acid changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   906   C1953353:Amino acid change [Finding]
   812   C0392747:changes [Functional Concept]
   812   C0443172:changes [Quantitative Concept]
   779 E C1705241:Change [Quantitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "tyrosine phosphorylation significantly."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1519726:Tyrosine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.157: Next, we examined the effect of tyrosine phosphorylation state on the ability of -synuclein to inhibit PLD activity. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of tyrosine phosphorylation state"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the ability of -synuclein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PLD activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149851:phospholipase D activity [Molecular Function]
   913   C1149838:phospholipase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.158: The cells were co-transfected with PLD1 or PLD2 along with the Y125F mutant construct or wild-type control -synuclein. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "PLD2 along with the Y125F mutant construct"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   744   C1414052:D2 [Gene or Genome]
   744   C1415944:D2 [Gene or Genome]

Phrase: "or"

Phrase: "wild-type control -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.159: After co-transfection, cells were trated with or without pervanadate (100M Na3VO4 and 500M H2O2). 

Phrase: "After co-transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "trated with"

Phrase: "or without pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(100M Na3VO4"

Phrase: "and"

Phrase: "500M H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.160: Mutation of Tyr125 to Phe slightly increased the inhibitory effect of -synuclein on pervanadate-induced PLD activity. 

Phrase: "Mutation of Tyr125"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to Phe slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031453:Phe [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the inhibitory effect of -synuclein on pervanadate-induced PLD activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.161: (Fig. 4A). 

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.162: The expression level of PLDs or -synuclein was similar in these transfection experiment (Fig. 4B). 

Phrase: "The expression level of PLDs or -synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "similar in these transfection experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.163: Thus, the tyrosine phosphorylation state of -synuclein appears to modulate PLD activity. 

Phrase: "Thus,"

Phrase: "the tyrosine phosphorylation state of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "PLD activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149851:phospholipase D activity [Molecular Function]
   913   C1149838:phospholipase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.164: View larger version (35K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.165: 4.  

Phrase: "4."
Processing 00000000.tx.166: Effect of tyrosine phosphorylation state of -synuclein on pervanadate-induced PLD activation. 

Phrase: "Effect of tyrosine phosphorylation state of -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on pervanadate-induced PLD activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]
Processing 00000000.tx.167: A, HEK 293cells were transiently transfected with various constructs and labeled with [3H]myristic acid for 18h. 

Phrase: "A,"

Phrase: "HEK 293cells"

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with various constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   737   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]myristic acid for 18h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0027138:Myristic Acid [Biologically Active Substance,Lipid]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.168: The cells were treated with or without pervanadate (100M Na3VO4 and 0.5mM H2O2) for 30min in the presence of 0.3% 1-butanol. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "or without pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(100M Na3VO4"

Phrase: "and"

Phrase: "0.5mM H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 30min"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.3% 1-butanol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0001977:Butanol [Lipid]
   812   C0089147:butanol [Lipid]
Processing 00000000.tx.169: The radioactivity incorporated into phosphatidylbutanol was measured as described under "Experimental Procedures." 

Phrase: "The radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "incorporated into phosphatidylbutanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0136784:phosphatidylbutanol [Lipid]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.170: Results are the meansS.D of three independent experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meansS.D of three independent experiments."
Processing 00000000.tx.171: *, p<0.05compared with cells co-transfected with -synuclein (wt) and PLD1 or PLD2 and treated with pervanadate. 

Phrase: "*,"

Phrase: "p<0.05compared with cells"

Phrase: "co-transfected with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(wt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "and"

Phrase: "treated with pervanadate."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.172: B, the lysates from the HEK 293cells used in the experiments were analyzed by Western blotting as described under "Experimental Procedures." 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the lysates from the HEK 293cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1881488:Lysate [Physical Object]

Phrase: "used in the experiments"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.173: -Synuclein Associates with PLD1 and PKC-- To explore the significance of this inhibition, we examined whether -synuclein interacts with PLD isozymes. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Associates with PLD1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0750490:Associate [Idea or Concept]
   790   C1418641:PLD1 [Gene or Genome]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the significance of this inhibition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts with PLD isozymes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0022173:Isozymes [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.174: HEK 293cells overexpressing -synuclein were treated for 20min with or without pervanadate. 

Phrase: "HEK 293cells"

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "treated for 20min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "with"

Phrase: "or without pervanadate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.175: The lysates were immunoprecipitated with anti-PLD antibody, and the precipitates were probed with monoclonal anti--synuclein antibody (Fig. 5A). 

Phrase: "The lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "immunoprecipitated with anti-PLD antibody,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   820   C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti D
   790   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0369095:antibody d [Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "the precipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "were"

Phrase: "probed with monoclonal anti"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0746619:monoclonal [Finding]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "--"

Phrase: "synuclein antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.176: The presence of -synuclein in the PLD immune complex was apparent. 

Phrase: "The presence of -synuclein in the PLD immune complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "apparent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.177: In a reciprocal experiment, -synuclein was immunoprecipitated by antibody to -synuclein. 

Phrase: "In a reciprocal experiment, -"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "immunoprecipitated by antibody to -synuclein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.178: Subsequent immunoblotting with the anti-PLD1 revealed PLD1 expression (Fig. 5A). 

Phrase: "Subsequent immunoblotting with the anti-PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "PLD1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.179: Interestingly, -synuclein was constitutively associated with PLD1. 

Phrase: "Interestingly, -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "constitutively"

Phrase: "associated with PLD1."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1418641:PLD1 [Gene or Genome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.180: Furtheremore, both -synuclein and PLD1 proteins were associated with PKC in cells overexpressing -synuclein (Fig. 5, B and C). 

Phrase: "Furtheremore,"

Phrase: "both -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PLD1 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "associated with PKC"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C3539645:PKC [Gene or Genome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.181: -Synuclein was also associated with PLD2 in co-transfection experiments (Fig. 5D). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "associated with PLD2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   770   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1414052:D2 [Gene or Genome]
   770   C1415944:D2 [Gene or Genome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in co-transfection experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.182: Interestingly, pervanadate did not alter the interaction of -synuclein with PKC or PLD. 

Phrase: "Interestingly,"

Phrase: "pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the interaction of -synuclein with PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "PLD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.183: To examine whether the effect of -synuclein on PLD is specific, we investigated the effect of -synuclein on the activity of other lipid modifying enzyme and their interaction (Fig. 6). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "the effect of -synuclein on PLD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "specific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of -synuclein on the activity of other lipid modifying enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.184: Pervanadate induced an increase in PLC activity in the HEK 293cells, but -synuclein did not affect PLC activity (Fig. 6A) and did not associate with PLC-1 (Fig. 6B) in cells overexpressing -synuclein, suggesting that the effect of -synuclein on PLD is specific. 

Phrase: "Pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "an increase in PLC activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in the HEK 293cells,"

Phrase: "but -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "PLC activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associate with PLC-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effect of -synuclein on PLD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]
Processing 00000000.tx.185: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.186: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.187: Interaction of -synuclein with PLD and PKC. 

Phrase: "Interaction of -synuclein with PLD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PKC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]
Processing 00000000.tx.188: A-C, HEK 293cells expressing -synuclein were stimulated without or with pervanadate (PV) (100M Na3VO4 and 0.5mM H2O2) for 20min. 

Phrase: "A-C, HEK 293cells"

Phrase: "expressing -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "stimulated without"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or with pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(PV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "(100M Na3VO4"

Phrase: "and"

Phrase: "0.5mM H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 20min."
Processing 00000000.tx.189: The cells were then lysed, and immunoprecipitates (IP) were prepared using anti-PLD, anti--synuclein (Syn), or anti-PKC antibody. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-PLD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0140430:Anti D [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "anti"

Phrase: "--"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-PKC antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.190: The immunoprecipitates were analyzed by SDS-polyacrylamide gel electrophoresis, followed by transfer of proteins to nitrocellulose membranes and Western blotting (Blot) with anti-PLD, anti--synuclein (Syn), or anti-PKC antibodies. 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "analyzed by SDS-polyacrylamide gel electrophoresis,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0936012:Analyzed [Research Activity]
   753   C1382104:Gel [Substance]

Phrase: "followed by transfer of proteins to nitrocellulose membranes"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0332283:Followed by [Temporal Concept]
           followed
   750   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0025255:Membranes [Tissue]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040671:Transfer [Mental Process]
   744   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   744   C1705822:Transfer [Activity]
   711 E C0596901:Membrane [Cell Component]
   711 E C1706182:Membrane [Manufactured Object]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(Blot"

Phrase: ")"

Phrase: "with anti-PLD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0140430:Anti D [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "anti"

Phrase: "--"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-PKC antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.191: D, HEK 293cells were transiently transfected with the empty vector (lane 1), PLD1 and -synuclein (lane 2), or PLD2 and -synuclein (lane 3). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "HEK 293cells"

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]
   704 E C0333668:Depleted [Functional Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.192: After immunoprecipitation with the anti-PLD or anti--synuclein antibody, the immunoprecipitates were then immunoblotted with anti--synuclein or anti-PLD antibody. 

Phrase: "After immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with the anti-PLD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0140430:Anti D [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "anti"

Phrase: "--"

Phrase: "synuclein antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "the immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunoblotted with anti"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "--"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "anti-PLD antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti D
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.193: "Mock" represents a mock-precipitated control. 

Phrase: """Mock"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a mock-precipitated control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.194: The blots shown are representative of three independent experiments. 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.195: View larger version (40K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.196: 6.  

Phrase: "6."
Processing 00000000.tx.197: -Synuclein does neither affect PLC activity nor interact with the enzyme. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "neither"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "PLC activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "nor"

Phrase: "interact with the enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
Processing 00000000.tx.198: A, subconfluent, quiescent cells were labeled with 2Ci/ml myo-[2-3H]inositol in inositol-free DMEM for 20h and then stimulated with pervanadate (100M Na3VO4 and 0.5mM H2O2) for 50min in the presence of 20mM LiCl, and total inositol phosphates were measured as described under "Experimental Procedures." 

Phrase: "A,"

Phrase: "subconfluent,"

Phrase: "quiescent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled with 2Ci/ml myo-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0439526:/mL [Quantitative Concept]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[2-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]inositol in inositol-free DMEM"

Phrase: "for 20h"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated with pervanadate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(100M Na3VO4"

Phrase: "and"

Phrase: "0.5mM H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 50min"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 20mM LiCl,"

Phrase: "and"

Phrase: "total inositol phosphates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0021554:Inositol Phosphates [Carbohydrate]
   827   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   827   C0031603:Phosphates [Inorganic Chemical,Pharmacologic Substance]
   793 E C0031701:phosphate [Organophosphorus Compound]
   793 E C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.199: Results are the meansS.D of three independent experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meansS.D of three independent experiments."
Processing 00000000.tx.200: B, the cells were then lysed, and immunoprecipitates (IP) were prepared using anti-PLC1 or anti--synuclein (Syn) antibody. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-PLC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418640:PLC1 [Gene or Genome]
   861   C3539716:PLC1 [Gene or Genome]

Phrase: "or"

Phrase: "anti"

Phrase: "--"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.201: The immunoprecipitates were then subjected to Western blotting (Blot) with anti-PLC1 or anti--synuclein (Syn). 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to Western blotting"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "(Blot"

Phrase: ")"

Phrase: "with anti-PLC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418640:PLC1 [Gene or Genome]
   861   C3539716:PLC1 [Gene or Genome]

Phrase: "or"

Phrase: "anti"

Phrase: "--"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.202: The blots shown are representative of three independent experiments. 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.203: Amphipathic Repeat Region and NAC Domain of -Synuclein Is Involved in the Interaction with PLD1-- To map the region on the -synuclein protein that is responsible for the interaction with PLD1, we prepared GST-fused human -synuclein protein, GST-Syn-whole (amino acid residues 1-140), GST-Syn-N (amino acid residues 1-60), GST-Syn-NAC (amino acid residues 61-95), and GST-Syn-C (amino acid residues 96-140) and used them in in vitro binding experiments. 

Phrase: "Amphipathic Repeat Region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "NAC Domain of -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Is"

Phrase: "Involved in the Interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "the region on the -synuclein protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1514562:Protein Region [Amino Acid Sequence]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "responsible for the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "with PLD1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "GST-fused human -synuclein protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "GST-Syn-whole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444667:Whole [Quantitative Concept]

Phrase: "(amino acid residues 1-140"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "GST-Syn-N (amino acid residues 1-60"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C2917660:Amino Acid [Pharmacologic Substance]
   793   C0001128:Acid [Chemical]
   793   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0202406:Acid [Laboratory Procedure]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   710 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "GST-Syn-NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0449432:Component [Manufactured Object]
   804   C1705248:Component [Conceptual Entity]

Phrase: "(amino acid residues 61-95"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "GST-Syn-C (amino acid residues 96-140"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C2917660:Amino Acid [Pharmacologic Substance]
   793   C0001128:Acid [Chemical]
   793   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0202406:Acid [Laboratory Procedure]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   710 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "them in in vitro binding experiments."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0021135:In Vitro [Intellectual Product]
   783   C1533691:in vitro [Qualitative Concept]
           vitro
   783   C2827718:In Vitro [Functional Concept]
   753   C0243122:binding [Functional Concept]
   753   C0681814:Experiments [Research Activity]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.204: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.205: 7, the GST-Syn-N and GST-Syn-NAC containing the amphipathic repeat region and the NAC domain, respectively, precipitated PLD1 from rat brain lysates. 

Phrase: "7,"

Phrase: "the GST-Syn-N"

Phrase: "and"

Phrase: "GST-Syn-NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0449432:Component [Manufactured Object]
   804   C1705248:Component [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the amphipathic repeat region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the NAC domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "respectively,"

Phrase: "precipitated PLD1 from rat brain lysates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1418641:PLD1 [Gene or Genome]
Processing 00000000.tx.206: Thus, these data suggest that the amphipathic repeat region and the NAC domain might be involved in the interaction with PLD1. 

Phrase: "Thus,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the amphipathic repeat region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the NAC domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "might"

Phrase: "be"

Phrase: "involved in the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with PLD1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]
Processing 00000000.tx.207: View larger version (58K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(58K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.208: 7.  

Phrase: "7."
Processing 00000000.tx.209: Amphipathic repeat region and NAC domain of -synuclein interact with PLD1. 

Phrase: "Amphipathic repeat region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "NAC domain of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interact with PLD1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1418641:PLD1 [Gene or Genome]
Processing 00000000.tx.210: -Synuclein was fragmented into individual domains consisting of NH2 terminus (1-60), NAC (61-95), COOH terminus (96-140). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "fragmented into individual domains"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0027361:Individual [Population Group]
   770   C0237401:Individual [Human]
   770   C0392767:Fragmented [Functional Concept]
   770   C1708096:Fragmented [Qualitative Concept]
   737 E C0332255:fragment [Functional Concept]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "consisting of NH2 terminus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002508:NH2 [Organic Chemical]
   770   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "(1-60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442768:1/60 [Finding]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "(61-95"

Phrase: ")"

Phrase: ","

Phrase: "COOH terminus"

Phrase: "(96-140"

Phrase: ")."
Processing 00000000.tx.211: The fragments and whole protein were cloned as GST fusion proteins, expressed in E.coli, and purified using glutathione-Sepharose beads. 

Phrase: "The fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "whole protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0444667:Whole [Quantitative Concept]

Phrase: "were"

Phrase: "cloned as GST fusion proteins,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   773   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0009013:cloned [Cell]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332466:Fusion [Functional Concept]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]
   726 E C1522642:Clone [Tissue]

Phrase: "expressed in E.coli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0014834:E coli [Bacterium]

Phrase: "and"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "glutathione-Sepharose beads."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]
Processing 00000000.tx.212: Equal amounts (1mg) of GST or GST fusion proteins (GST-Syn fragment) were incubated with rat brain extract as described under "Experimental Procedures." 

Phrase: "Equal amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "(1mg"

Phrase: ")"

Phrase: "of GST"

Phrase: "or"

Phrase: "GST fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(GST-Syn fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "incubated with rat brain extract"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C2828366:Extract [Substance]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.213: The precipitated proteins were subjected to immunoblot analysis using antibody against PLD1 (upper panel). 

Phrase: "The precipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody against PLD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.214: The amount of the GST fusion protein was visualized by Western blotting using anti-GST antibody (lower panel). 

Phrase: "The amount of the GST fusion protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "visualized by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0234621:Visualized [Functional Concept]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-GST antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.215: The results shown are representative of three separate experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three separate experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.216: -Synuclein Associates with a Region (Amino Acids 1-331) of PLD1-- Next, we analyzed the interaction site(s) of PLD1 with -synuclein. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Associates with a Region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]

Phrase: "(Amino Acids 1-331"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "of PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "--"

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the interaction site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "s) of PLD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1418641:PLD1 [Gene or Genome]
   790   C2603362:S' [Clinical Attribute]

Phrase: "with -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.217: To identify the PLD1 sequence involved in the -synuclein binding, we constructed the GST fusion proteins shown in Fig. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the PLD1 sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "involved in the -synuclein binding,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1314939:Involved [Functional Concept]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "the GST fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.218: 8A. 

Phrase: "8A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553640:8a [Medical Device]
Processing 00000000.tx.219: The lysates from rat brain were precipitated with GST-PLD1 fragments (Fig. 8B) and analyzed by Western blotting with anti--synuclein antibody. 

Phrase: "The lysates from rat brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "precipitated with GST-PLD1 fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   760   C1418641:PLD1 [Gene or Genome]
   726 E C1708096:Fragment [Qualitative Concept]
   726   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti"

Phrase: "--"

Phrase: "synuclein antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.220: GST-PLD1 (amino acid 1-331) was found to be the region that most potently bound to -synuclein. 

Phrase: "GST-PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1418641:PLD1 [Gene or Genome]

Phrase: "(amino acid 1-331"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "that most potently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "to -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.221: It appears, therefore, that the region between amino acids 1and 331containing the phox and pleckstrin homology domains may be important for the interaction with -synuclein. 

Phrase: "It"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: ","

Phrase: "therefore,"

Phrase: "that"

Phrase: "the region between amino acids 1and 331containing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   732   C1515860:Acidic Region [Amino Acid Sequence]

Phrase: "the phox"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0768581:phOx [Organic Chemical]

Phrase: "and"

Phrase: "pleckstrin homology domains"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1518792:Pleckstrin-Homology Domain [Amino Acid Sequence]
   827   C0071246:pleckstrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1334043:Homology [Gene or Genome]
   827   C1418644:PLECKSTRIN [Gene or Genome]
   827   C2697616:Homology [Qualitative Concept]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "important for the interaction"

Phrase: "with -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.222: View larger version (46K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.223: 8.  

Phrase: "8."
Processing 00000000.tx.224: -Synuclein associates with phox and pleckstrin homology domains of PLD1. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associates with phox"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0750490:Associate [Idea or Concept]
   790   C0768581:phOx [Organic Chemical]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "pleckstrin homology domains of PLD1."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   828   C1518792:Pleckstrin-Homology Domain [Amino Acid Sequence]
   760   C0071246:pleckstrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1334043:Homology [Gene or Genome]
   760   C1418644:PLECKSTRIN [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.225: A, a schematic representation of the structure of PLD1 is shown on the top. 

Phrase: "A,"

Phrase: "a schematic representation of the structure of PLD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1514861:Representation [Conceptual Entity]
   744   C1882932:Representation [Activity]

Phrase: "is"

Phrase: "shown on the top."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704458:Top [Spatial Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.226: The possible functions of each box have been proposed or demonstrated in Ref. 

Phrase: "The possible functions of each box"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "or"

Phrase: "demonstrated in Ref."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1425988:REF [Gene or Genome]
Processing 00000000.tx.227: 24. 

Phrase: "24."
Processing 00000000.tx.228: Boxes are the regions of highly conserved sequences in PLD. 

Phrase: "Boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0179400:boxes [Manufactured Object]
  1000   C1638312:Boxes [Quantitative Concept]
   966 E C1533124:Box [Medical Device]

Phrase: "are"

Phrase: "the regions of highly conserved sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "in PLD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.229: PX, phox domain; 

Phrase: "PX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332132:PX [Qualitative Concept]

Phrase: "phox domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.230: PH, pleckstrin homology-like domain; 

Phrase: "PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "pleckstrin homology-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1334043:Homology [Gene or Genome]
   861   C2697616:Homology [Qualitative Concept]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.231: I-IV, conserved regions in the PLD family (24). 

Phrase: "I-IV,"

Phrase: "conserved regions in the PLD family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.232: loop, loop region, CT, COOH terminus. 

Phrase: "loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "loop region,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "COOH terminus."
Processing 00000000.tx.233: B, equal amounts (1mg) of GST or GST fusion proteins (GST-PLD1 fragments, F1-F7) were incubated with rat brain extract as described under "Experimental Procedures." 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "equal amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "(1mg"

Phrase: ")"

Phrase: "of GST"

Phrase: "or"

Phrase: "GST fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(GST-PLD1 fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "F1-F7)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015502:F7 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1333523:F7 [Gene or Genome]

Phrase: "were"

Phrase: "incubated with rat brain extract"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C2828366:Extract [Substance]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.234: The precipitated proteins were subjected to immunoblot analysis using antibody against -synuclein (upper panel). 

Phrase: "The precipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody against -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.235: The amount of the GST fusion protein was visualized by Western blotting using anti-GST antibody (lower panel). 

Phrase: "The amount of the GST fusion protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "visualized by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0234621:Visualized [Functional Concept]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-GST antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.236: The results shown are representative of three separate experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three separate experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.237: Interaction of PLD1 with the -Synuclein in Rat Brain-- As with HEK 293cells overexpressing -synuclein, we found that in rat brain tissues, PLD1 co-precipitates with endogeneous -synuclein by using a co-immunoprecipitation method on rat brain (Fig. 9A). 

Phrase: "Interaction of PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "with the -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in Rat Brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "-"

Phrase: "-"

Phrase: "As with HEK 293cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0013935:Embryonic [Embryonic Structure]
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1514845:KIDNEY [Tissue]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that in rat brain tissues,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0440746:brain tissues [Tissue]
   806   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   773 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0040300:Tissues [Tissue]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "co-precipitates with endogeneous -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a co-immunoprecipitation method on rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "(Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.238: We tried to further check whether PLD1 co-localized with -synuclein. 

Phrase: "We"

Phrase: "tried"

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "check"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Check [Activity]

Phrase: "whether"

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "co-localized with -synuclein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392752:Localized [Spatial Concept]
Processing 00000000.tx.239: Recently, we reported endogeneous PLD1 expression in neurons of the substantia nigra par compact (28), which are affected in PD. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "endogeneous PLD1 expression in neurons of the substantia nigra par"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "compact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1333134:Compact [Finding]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "affected in PD."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.240: Expression of -synuclein has been also reported in these neurons (38, 39). 

Phrase: "Expression of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "also"

Phrase: "reported in these neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0027882:Neurons [Cell]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.241: Therefore, rat brain sections were double-immunolabeled with anti-PLD1 and anti--synuclein antibodies to identify the co-localization of -synuclein with PLD1 in the same neuron. 

Phrase: "Therefore,"

Phrase: "rat brain sections"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "double-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "immunolabeled with anti-PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1418641:PLD1 [Gene or Genome]

Phrase: "and"

Phrase: "anti"

Phrase: "--"

Phrase: "synuclein antibodies to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "identify"

Phrase: "the co-localization of -synuclein with PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the same neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.242: Examination with confocal microscopy revealed that all -synuclein immunoreactive neurons in the substantia nigra pars compacta co-localized with PLD1 immunoreactivity (Fig. 9B). 

Phrase: "Examination with confocal microscopy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0026018:Microscopic examination [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "all -synuclein immunoreactive neurons in the substantia nigra pars compacta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0027882:Neurons [Cell]

Phrase: "co-localized with PLD1 immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392752:Localized [Spatial Concept]
   760   C0597879:immunoreactivity [Molecular Function]
   760   C1418641:PLD1 [Gene or Genome]

Phrase: "(Fig. 9B"

Phrase: ")."
Processing 00000000.tx.243: Taken together, these results suggest that regulation of PLD by -synuclein might occur through in vivo interaction. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that regulation of PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "occur through in vivo interaction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C1704675:Interaction [Functional Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.244: View larger version (65K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(65K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.245: 9.  

Phrase: "9."
Processing 00000000.tx.246: Interaction of PLD1 with -synuclein in rat brain. 

Phrase: "Interaction of PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.247: A, -synuclein and PLD was co-immunoprecipitated from rat brain lysates using antibody to PLD or -synuclein. 

Phrase: "A, -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "co-immunoprecipitated from rat brain lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   719   C0301871:Immunoprecipitate [Immunologic Factor]
   719   C1881488:Lysate [Physical Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody to PLD or -synuclein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0369095:antibody d [Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.248: The resulting immunoprecipitates were immunoblotted with antibodies to -synuclein or PLD. 

Phrase: "The resulting immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "immunoblotted with antibodies to -synuclein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0020985:Immunoblot [Laboratory Procedure]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "PLD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.249: Mock represents a mock-precipitated control. 

Phrase: "Mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a mock-precipitated control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.250: B, Cy3-labeled, PLD1 immunoreactive cells and fluorescein isothiocyanate-labeled, -synuclein immunoreactive cells in the neuron of the substantia nigra pars compacta were visualized with confocal microscopy. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cy3-labeled, PLD1 immunoreactive cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "fluorescein isothiocyanate-labeled, -synuclein immunoreactive cells in the neuron"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "of the substantia nigra pars compacta"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   902   C0222661:Substantia compacta [Tissue]
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   812   C3283876:Compacta [Eukaryote]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]

Phrase: "were"

Phrase: "visualized with confocal microscopy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0242842:Microscopy, Confocal [Laboratory Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.251: Superimposed images display the co-localization of, respectively, PLD1-labeled and -synuclein-labeled neurons in the substantia nigra pars compacta. 

Phrase: "Superimposed images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "the co-localization of,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "respectively,"

Phrase: "PLD1-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1708632:Labeled [Qualitative Concept]
   827 E C0181496:Label [Manufactured Object]
   827 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and -"

Phrase: "synuclein-labeled neurons in the substantia nigra pars compacta."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0027882:Neurons [Cell]
Processing 00000000.tx.252: Scale bars: 50m. 

Phrase: "Scale bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ":"

Phrase: "50m."
Processing 00000000.tx.253: The results shown are representative of two separative experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of two separative experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.254: Quantification of Eosinophilic Inclusions-- Since -synuclein was observed to interact with both PLD1 and PLD2, we assessed their functional significance in terms of the formation of intracellular cytoplasmic inclusions, which is pathological characteristics of PD (8, 9, 40, 41). 

Phrase: "Quantification of Eosinophilic Inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "--"

Phrase: "Since -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with both PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1418641:PLD1 [Gene or Genome]

Phrase: "and"

Phrase: "PLD2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "their functional significance in terms of the formation of intracellular cytoplasmic inclusions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0237881:Significance [Quantitative Concept]
   736   C0750502:Significance [Idea or Concept]

Phrase: "which"

Phrase: "is"

Phrase: "pathological characteristics of PD (8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "9,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.255: The morphological composition of cells was determined by hematoxylin and eosin (H&E) staining to evaluate the formation of inclusion bodies in cells transfected with both PLD and -synuclein proteins (Fig. 10A). 

Phrase: "The morphological composition of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0486616:Composition [Clinical Attribute]
   760   C1555710:composition [Idea or Concept]

Phrase: "was"

Phrase: "determined by hematoxylin and eosin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: "(H&E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the formation of inclusion bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with both PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "synuclein proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 10A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553642:10a [Medical Device]

Phrase: ")."
Processing 00000000.tx.256: Consistent with the previous result, we observed that ~6% cells out of total cell numbers had eosinophilic inclusion bodies in cytoplasm when HEK 293cells were co-transfected with constructs encoding NAC and full-length synphilin-1, which were used as a positive control (Fig. 10B) (16). 

Phrase: "Consistent with the previous result,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that ~6% cells out of total cell numbers"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C1441375:Cells.total [Cell]
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "eosinophilic inclusion bodies in cytoplasm"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   808   C2700430:Cytoplasmic inclusion bodies [Finding]
   806   C0007637:Inclusion Bodies [Cell Component]
   792 E C0205708:Cytoplasmic inclusion body [Cell Component]
           Cytoplasmic inclusion
   781   C0333468:Eosinophilic body [Acquired Abnormality]
   762   C0333774:Cytoplasmic bodies [Cell Component]
   760   C0242821:bodies [Human]
   760   C1512693:Inclusion [Qualitative Concept]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "when"

Phrase: "HEK 293cells"

Phrase: "were"

Phrase: "co-transfected with constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2827421:Construct [Classification]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "full-length synphilin-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
   861   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "were"

Phrase: "used as a positive control"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "(Fig. 10B"

Phrase: ")"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.257: The percentage of cells that develop inclusion bodies is ~10-20%, out of cells expressing both NAC and synphilin-1 based on a transfection efficiency of 30-40%, which was calculated using a green fluorescent protein reporter plasmid. 

Phrase: "The percentage of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "that"

Phrase: "develop"

Phrase: "inclusion bodies is ~10-20%,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0007637:Inclusion Bodies [Cell Component]
   804   C0242821:bodies [Human]
   804   C1512693:Inclusion [Qualitative Concept]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]

Phrase: "out of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "both NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "based on a transfection efficiency of 30-40%,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0013682:Efficiency [Quantitative Concept]
   744   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   744   C0439509:/40 [Temporal Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "which"

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a green fluorescent protein reporter plasmid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.258: In contrast, cells co-transfected constructs encoding NAC and PLD1 or NAC and PLD2 exhibited only ~1-2% of eosinophilic inclusion bodies (Fig. 10B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected"

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "only ~1-2% of eosinophilic inclusion bodies"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0007637:Inclusion Bodies [Cell Component]
   757   C0333468:Eosinophilic body [Acquired Abnormality]
   748   C0205171:Only [Quantitative Concept]
   748   C0242821:bodies [Human]
   748   C0333930:Eosinophilic [Functional Concept]
   748   C1512693:Inclusion [Qualitative Concept]
   748   C1720467:Only [Intellectual Product]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "(Fig. 10B"

Phrase: ")."
Processing 00000000.tx.259: In addition, cells co-expressing -synuclein and PLD1 or PLD2 revealed same effect that was observed in cells co-exprexressing NAC and PLDs (data not shown). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "same effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "observed in cells co-exprexressing NAC"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   750   C0243092:Cell component [Cell Component]
   750   C1178969:Cell Component [Cell Component]
   744   C0007634:Cells [Cell]
   744   C0449432:Component [Manufactured Object]
   744   C1441672:Observed [Functional Concept]
   744   C1518422:Non [Functional Concept]
   744   C1705248:Component [Conceptual Entity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "PLDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0044369:PLD [Organic Chemical]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.260: This is similar to the results that were obtained from cells expressing any protein alone, such as NAC, -synuclein, PLD1, or PLD2 protein. 

Phrase: "This"

Phrase: "is"

Phrase: "similar to the results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "obtained from cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1301820:Obtained [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1706701:Obtain [Activity]
   756 E C1948049:Cell [Spatial Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "expressing"

Phrase: "any protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "such as NAC, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PLD1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "PLD2 protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
Processing 00000000.tx.261: These results suggest that the specific interaction between PLDs and -synuclein might not be an essential feature in the formation of inclusion bodies in mammalian cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the specific interaction between PLDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "an essential feature in the formation of inclusion bodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1521970:Feature [Qualitative Concept]
   742   C1706388:Feature [Conceptual Entity]
   742   C2346469:Feature [Qualitative Concept]
   742   C2348519:Feature [Qualitative Concept]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.262: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.263: 10.  

Phrase: "10."
Processing 00000000.tx.264: Formation of eosinophilic cytoplasmic inclusion bodies. 

Phrase: "Formation of eosinophilic cytoplasmic inclusion bodies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.265: A, HEK 293cells co-transfected with constructs encoding NAC (amino acids 61-95 of -synuclein) and full-length synphilin-1 develop cytoplasmic eosinophilic inclusions when stained with H&E. 

Phrase: "A,"

Phrase: "HEK 293cells"

Phrase: "co-transfected with constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2827421:Construct [Classification]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "(amino acids 61-95 of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "full-length synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
   861   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "develop"

Phrase: "cytoplasmic eosinophilic inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0205708:Cytoplasmic Inclusions [Cell Component]
   901   C3279277:Eosinophilic inclusions [Finding]
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: "when"

Phrase: "stained with H&E."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   891   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   781   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.266: The inclusions were hardly detected in cells co-transfected with constructs encoding NAC plus PLD1 or NAC plus PLD2. 

Phrase: "The inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "were"

Phrase: "hardly"

Phrase: "detected in cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2827421:Construct [Classification]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "NAC plus PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "NAC plus PLD2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   799   C1414052:D2 [Gene or Genome]
   799   C1415944:D2 [Gene or Genome]
Processing 00000000.tx.267: B, quantification of eosinophilic inclusion formation in HEK 293cells transfected with various constructs. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantification of eosinophilic inclusion formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "in HEK 293cells"

Phrase: "transfected with various constructs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   737   C2827421:Construct [Classification]
Processing 00000000.tx.268: Approximately 6% of cells co-transfected with constructs encoding NAC and synphilin-1 co-stained eosinophilic inclusions, whereas co-transfection of constructs encoding NAC and PLD1 or PLD2 resulted in the formation of less than 1% of eosinophilic inclusion. 

Phrase: "Approximately 6% of cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0332232:Approximately [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2827421:Construct [Classification]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "co-stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2986582:Stained [Qualitative Concept]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "eosinophilic inclusions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3279277:Eosinophilic inclusions [Finding]
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "whereas"

Phrase: "co-transfection of constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "resulted in the formation of less"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "than 1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "of eosinophilic inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.269: Values are expressed as percentages of cells containing eosinophilic protein aggregates with pinkish color relative to total cells. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as percentages of cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726   C0439165:Percentage [Quantitative Concept]
   726 E C1269647:Cell [Cell]
   726   C1549488:Percentage [Idea or Concept]
   726   C1561533:Percentage [Idea or Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "eosinophilic protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aggregates with pinkish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205418:Aggregate [Qualitative Concept]

Phrase: "color"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009393:Color [Natural Phenomenon or Process]
  1000   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
  1000   C1705245:Color [Pharmacologic Substance]

Phrase: "relative to total cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.270: Results are the meansS.D of three independent experiments.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meansS.D of three independent experiments."
Processing 00000000.tx.271: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES We demonstrate for the first time that -synuclein binds to both PLD1 and PLD2 and inhibits its enzymatic activity in human cell lines. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "demonstrate for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to both PLD1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1418641:PLD1 [Gene or Genome]

Phrase: "and"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "its enzymatic activity in human cell lines."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C2267219:Enzymatic Activity [Molecular Function]
   774   C0020115:Human Activity [Activity]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.272: -Synuclein has been implicated in Parkinson's and Alzheimer's disease. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in Parkinson's"

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.273: It is of great interest to determine the specific function(s) of -synuclein because of its potential importance in the pathogenesis of these diseases. 

Phrase: "It"

Phrase: "is of great interest to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0543488:Interest [Mental Process]
   760   C0549177:Great [Quantitative Concept]
   760   C1704243:Great [Quantitative Concept]

Phrase: "determine"

Phrase: "the specific function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "("

Phrase: "s)"

Phrase: "of -synuclein because of its potential importance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of these diseases."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.274: The link between -synuclein and PLD appears to be particularly intriguing, because -synuclein inhibits PLD2 activity in vitro (20), and PLD activity was significantly increased in in Alzheimer's disease brain tissues as compared with control tissues (42). 

Phrase: "The link between -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "particularly intriguing,"

Phrase: "because -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PLD2 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C1149838:phospholipase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "PLD activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149851:phospholipase D activity [Molecular Function]
   913   C1149838:phospholipase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased in"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   833   C0205217:Increased [Quantitative Concept]
   833   C0442805:Increased [Functional Concept]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C1301820:Obtain [Functional Concept]
   740 E C1706701:Acquire [Activity]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "in Alzheimer's disease brain tissues"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0440746:brain tissues [Tissue]
   827 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0040300:Tissues [Tissue]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   779 E C1547928:Tissue [Intellectual Product]

Phrase: "as"

Phrase: "compared with control tissues"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0040300:Tissues [Tissue]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.275: Recently, we confirmed the increase in PLD1 protein in AD brain and also observed that PLD co-localized with -amyloid (data not shown). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the increase in PLD1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "co-localized with -amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0392752:Localized [Spatial Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.276: Taken together, these results suggest that modulation of PLD by -synuclein might play a role in some aspects of the pathophysiology of neurodegenerative diseases. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that modulation of PLD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in some aspects of the pathophysiology of neurodegenerative diseases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.277: Further investigations of the regulation of PLD by -synuclein could provide valuable insights into the role of these proteins play in normal and pathological conditions. 

Phrase: "Further investigations of the regulation of PLD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1261322:Investigations [Health Care Activity]
   711 E C1552578:investigation [Idea or Concept]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "valuable insights into the role of these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:insights [Mental Process]

Phrase: "play in normal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0032214:Play [Daily or Recreational Activity]
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C0600138:play [Finding]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "pathological conditions."
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C1521733:Pathological [Functional Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.278: To investigate this issue, we examined the regulation of PLD by -synuclein in HEK 293cells overexpressing -synuclein. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "this issue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the regulation of PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in HEK 293cells"

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.279: Pervanadate or PMA-stimulated PLD activation was decreased in cells overexpressing -synuclein, compared with that of vector-transfected cells. 

Phrase: "Pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "PMA-stimulated PLD activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "decreased in cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0007634:Cells [Cell]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C0547047:Decrease [Quantitative Concept]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "compared with that of vector-transfected cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C1707455:Compared [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.280: Cells overexpressing Ala53 Thr (A53T) and Ala30 Pro (A30P) mutant -synuclein, which have been associated with familial forms of PD, showed greater inhibition of PLD than vector-transfected cells. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "Ala53 Thr (A53T)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Ala30 Pro (A30P) mutant -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "have"

Phrase: "been"

Phrase: "associated with familial forms of PD,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   773   C1832428:Familial form [Finding]
   753   C0015576:familial [Family Group]
   753   C0241888:Familial [Functional Concept]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1522492:Form [Functional Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "greater inhibition of PLD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "than vector-transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.281: By immunoprecipitation and Western blot analysis using an anti-PLD antibody, the HEK 293cells were found to express similar levels of ~120-kDa PLD1 protein. 

Phrase: "By immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-PLD antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti D
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "the HEK 293cells"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "similar levels of ~120-kDa PLD1 protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.282: However, the 105-kDa PLD2 protein was not detected in any of the cell lines, indicating that the PLD activity shown in these cells is due to mainly to PLD1. 

Phrase: "However,"

Phrase: "the 105-kDa PLD2 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in any of the cell lines,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0007600:Cell lines [Cell]
   748   C0007634:Cell [Cell]
   748   C0205132:lines [Spatial Concept]
   748   C0442726:Detected [Finding]
   748   C1269647:Cell [Cell]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the PLD activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149851:phospholipase D activity [Molecular Function]
   913   C1149838:phospholipase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "shown in these cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1547282:Show [Intellectual Product]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "is due to mainly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0678226:Due to [Functional Concept]
           due
   770   C3146286:Due [Idea or Concept]

Phrase: "to PLD1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]
Processing 00000000.tx.283: Using in vitro studies, -synuclein has been reported to inhibit PLD2 activity more potently than PLD1 activity (20). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in vitro studies, -"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PLD2 activity more potently than PLD1 activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   767   C1149838:phospholipase activity [Molecular Function]
   744   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1414052:D2 [Gene or Genome]
   744   C1415944:D2 [Gene or Genome]
   744   C1418641:PLD1 [Gene or Genome]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.284: However, we found that in co-transfection experiments, -synuclein inhibited pervanadate-stimulated PLD activity. 

Phrase: "However,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that in co-transfection experiments, -"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "pervanadate-stimulated PLD activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C1149851:phospholipase D activity [Molecular Function]
   853   C1149838:phospholipase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.285: This suggests that -synuclein can inhibit both forms of PLD. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "both"

Phrase: "forms of PLD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]
Processing 00000000.tx.286: The ability of -synuclein to inhibit PLD1 in cells might reflect differences between in vitro and in vivo environments. 

Phrase: "The ability of -synuclein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PLD1 in cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1418641:PLD1 [Gene or Genome]

Phrase: "might"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "differences between in vitro"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "in vivo environments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014406:Environments [Spatial Concept]
   734   C1515655:In Vivo [Spatial Concept]
Processing 00000000.tx.287: Recently, -synuclein was reported to inhibit PKC activity in HEK 293cells (15), which could contribute to the inhibition of PLD activity. 

Phrase: "Recently, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PKC activity in HEK 293cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1150572:PKC activity [Molecular Function]
   774   C0020115:Human Activity [Activity]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "could"

Phrase: "contribute to the inhibition of PLD activity."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C1149851:phospholipase D activity [Molecular Function]
   770   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1149838:phospholipase activity [Molecular Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1880177:Contribute [Activity]
   744   C3463820:Inhibition [Activity]
Processing 00000000.tx.288: Inhibition of PKC by -synuclein could contribute to the decrease in pervanadate-induced PLD activation in cells overexpressing -synuclein. 

Phrase: "Inhibition of PKC"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "by -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "contribute to the decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1880177:Contribute [Activity]

Phrase: "in pervanadate-induced PLD activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.289: However, it is possible that this inhibition might also result from a direct interaction between PLD and -synuclein. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "this inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "might"

Phrase: "also"

Phrase: "result from a direct interaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0439851:Direct [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1704675:Interaction [Functional Concept]
   760   C1947931:Direct [Qualitative Concept]
   760   C2825142:Result [Finding]

Phrase: "between PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.290: Here we demonstrated that -synuclein is constitutively associated with PLD1 in cells, and -synuclein forms a triple complex with PLD and PKC in a ligand-independent manner. 

Phrase: "Here"

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "constitutively"

Phrase: "associated with PLD1"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1418641:PLD1 [Gene or Genome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a triple complex with PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "PKC in a ligand-independent manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3539645:PKC [Gene or Genome]
Processing 00000000.tx.291: The association between -synuclein and PKC is consistent with prior results observed by Ostrerova and colleagues (15). 

Phrase: "The association between -synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "is"

Phrase: "consistent with prior results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "observed by Ostrerova"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.292: We also demonstrated that -synuclein associates with PLD2 in co-transfected cells. 

Phrase: "We also"

Phrase: "demonstrated"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associates with PLD2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   770   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0750490:Associate [Idea or Concept]
   770   C1414052:D2 [Gene or Genome]
   770   C1415944:D2 [Gene or Genome]
   770   C1706221:Associate [Professional or Occupational Group]

Phrase: "in"

Phrase: "co-transfected"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.293: We found that -synuclein co-immunoprecipitated with endogeneous PLD from rat brain tissue and is co-localized with PLD in neurons in the substantia nigra pars compacta of rat brain, indicating that these two proteins interact in vivo. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-immunoprecipitated with endogeneous PLD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "from rat brain tissue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0440746:Brain tissue [Tissue]
   901   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   901   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0040300:Tissue [Tissue]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "co-localized with PLD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0392752:Localized [Spatial Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in the substantia nigra pars compacta"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   902   C0222661:Substantia compacta [Tissue]
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   812   C3283876:Compacta [Eukaryote]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]

Phrase: "of rat brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "indicating"

Phrase: "that"

Phrase: "these two proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interact"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.294: The PLD1 binding site in -synuclein resides in the amino acid residues 1-95 containing 6or 7conserved repeats with the consensus core sequence KTKEGV. 

Phrase: "The PLD1 binding site in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resides in the amino acid residues 1-95 containing 6or 7conserved"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C2917660:Amino Acid [Pharmacologic Substance]
   738   C0001128:Acid [Chemical]
   738   C0202406:Acid [Laboratory Procedure]
   738   C0332256:Containing [Functional Concept]
   738   C2700400:Containing [Activity]
   738   C2982691:Reside [Activity]
   704   C1709915:Residue [Conceptual Entity]
   704   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "repeats with the consensus core sequence KTKEGV."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   774   C0079160:Consensus Sequence [Nucleotide Sequence]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0205341:Repeat [Functional Concept]
   748   C0376298:Consensus [Social Behavior]
   748   C0444669:Core [Spatial Concept]
   748   C1167518:core [Cell Component]
   748   C1519249:Sequence [Functional Concept]
   748   C1547730:Repeat [Temporal Concept]
   748   C1705914:Repeat [Conceptual Entity]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]
Processing 00000000.tx.295: -Synuclein has been shown to interact with phospholipids. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with phospholipids."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   756 E C0202177:Phospholipid [Laboratory Procedure]
Processing 00000000.tx.296: This interaction is also facilitated mainly by a conserved NH2-terminal 95residues, which changes its structure from "unfolded" to -helical upon binding to lipids (12). 

Phrase: "This interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "facilitated"

Phrase: "mainly by a conserved NH2-terminal 95residues,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0002508:NH2 [Organic Chemical]
   748   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: "which"

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "its structure from """
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678594:Structure [Spatial Concept]

Phrase: "unfolded"

Phrase: """ to -helical upon binding"

Phrase: "to lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.297: Because of -synucleins ability to interact with lipids and their association with synaptic vesicles, it has been suggested that synucleins might be involved in intracellular vesicular trafficking (43). 

Phrase: "Because of -synucleins ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "interact with lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023779:Lipids [Lipid]

Phrase: "and"

Phrase: "their association with synaptic vesicles,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "be"

Phrase: "involved in intracellular vesicular"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C0205378:Vesicular [Qualitative Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.298: Tau interacts with the acidic COOH-terminal region (residues 89-140) of -synuclein through its microtubule-binding domain. 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "interacts with the acidic COOH-terminal region"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C1515860:Acidic Region [Amino Acid Sequence]
   748   C0001128:Acidic [Chemical]
   748   C0017446:Region [Geographic Area]
   748   C0205088:Terminal [Temporal Concept]
   748   C0205147:Region [Spatial Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: "(residues 89-140"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "of -synuclein through its microtubule-binding domain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.299: This opens the possibility that -synuclein might have a bridging functions that might serve to bring different classes of ligands together. 

Phrase: "This"

Phrase: "opens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: "the possibility"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "have"

Phrase: "a bridging functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "that"

Phrase: "might"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bring"

Phrase: "different classes of ligands together."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0684000:class differences [Finding]
   760   C0456387:Class [Intellectual Product]
   760   C1705943:Class [Classification]
Processing 00000000.tx.300: -Synuclein binds to a region between amino acids 1and 331of PLD1. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to a region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "between amino acids 1and 331of PLD1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1418641:PLD1 [Gene or Genome]
Processing 00000000.tx.301: This region contains the NH2-terminal pleckstrin homology and phox domains, which are known to be involved in protein-protein interaction as well as binding of phospholipids (44). 

Phrase: "This region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the NH2-terminal pleckstrin homology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1334043:Homology [Gene or Genome]
   812   C2697616:Homology [Qualitative Concept]

Phrase: "and"

Phrase: "phox domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "which"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in protein-protein interaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0872079:Protein-Protein Interaction [Molecular Function]
           interaction protein
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1314939:Involved [Functional Concept]
   760   C1704675:Interaction [Functional Concept]

Phrase: "as well as"

Phrase: "binding of phospholipids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C1148642:Phospholipid Binding [Molecular Function]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.302: The interaction sites of PLD2 with -synuclein showed similar patterns as with PLD1 (data not shown). 

Phrase: "The interaction sites of PLD2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   773   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Patterns [Spatial Concept]

Phrase: "as with PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1418641:PLD1 [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.303: -Synuclein did not affect the activity of PLC and other lipid-modifying enzymes and did not associate with PLC-1 in cells overexpressing -synuclein, suggesting that the effect of -synuclein on PLD is specific. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the activity of PLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "other lipid-modifying enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associate with PLC-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effect of -synuclein on PLD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]
Processing 00000000.tx.304: Protein-tyrosine phosphorylation is thought to be important in regulating synaptic function and plasticity (45, 46). 

Phrase: "Protein-tyrosine phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   901   C1519726:Tyrosine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important in"

Phrase: "regulating"

Phrase: "synaptic function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678558:Plasticity [Natural Phenomenon or Process]
   928 E C0032167:Plastic [Substance]

Phrase: "(45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.305: It was reported recently that -synuclein can be tyrosine-phosphorylated by the Src family tyrosine kinase in a co-transfection experiment and in vitro using purified kinases (37). 

Phrase: "It"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "tyrosine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phosphorylated by the Src family tyrosine kinase"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   853   C0282625:SRC Family Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           src Tyrosine Kinases
           src-Family Kinases
           src Kinases
   778   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
           Kinase
   748   C0015576:Family [Family Group]
   748   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1704727:Family [Conceptual Entity]

Phrase: "in a co-transfection experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "purified kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.306: This tyrosine phosphorylation occurs primarily on tyrosine 125.

Phrase: "This tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "primarily on tyrosine 125."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.307: It is difficult to speculate on the functional consequences of tyrosine phosphorylation of -synuclein, because its normal function has not been elucidated definitively. 

Phrase: "It"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "speculate on the functional consequences of tyrosine phosphorylation of -synuclein,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C1519726:Tyrosine Phosphorylation [Molecular Function]
   743   C0686907:Consequence of [Functional Concept]
           consequences
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205245:Functional [Functional Concept]
   739   C0542341:Functional [Functional Concept]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C2700217:Functional [Conceptual Entity]

Phrase: "because"

Phrase: "its normal function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "elucidated"

Phrase: "definitively."
Processing 00000000.tx.308: The putative role of -synuclein in regulating intracellular vesicular trafficking and signaling appears particularly interesting. 

Phrase: "The putative role of -synuclein in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulating"

Phrase: "intracellular vesicular"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205378:Vesicular [Qualitative Concept]
   789 E C0333262:VESICLES [Acquired Abnormality]
   789 E C1622418:vesicle [Cell Component]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "particularly"

Phrase: "interesting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]
Processing 00000000.tx.309: Mice lacking -synuclein show abnormal dopamine release (47). 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "abnormal dopamine release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.310: -Synuclein exists in the cytoplasm in presynaptic neurons, but is also loosely associated with synaptic vesicles (48). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exists in the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C2987476:Exist [Conceptual Entity]

Phrase: "in presynaptic neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "but"

Phrase: "is"

Phrase: "also loosely"

Phrase: "associated with synaptic vesicles"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0039065:Synaptic Vesicles [Cell Component]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1622418:vesicle [Cell Component]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.311: Covalent modification, such as phosphorylation, is a likely candidate for regulation of -synuclein at the synapse, and covalent modification could be important in modulating its function. 

Phrase: "Covalent modification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "such as phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "a likely candidate for regulation of -synuclein"

Phrase: "at the synapse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039062:Synapse [Body Space or Junction]

Phrase: "and"

Phrase: "covalent modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "important in modulating"

Phrase: "its function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.312: Although the functional consequences of phosphorylation of the tyrosine 125residue of -synuclein remain to be elucidated, tyrosine phosphorylation could regulate the ability of -synuclein to bind synaptic vesicles and thereby regulate protein-protein interactions. 

Phrase: "Although"

Phrase: "the functional consequences of phosphorylation of the tyrosine 125residue of -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated"

Phrase: ","

Phrase: "tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "could"

Phrase: "regulate"

Phrase: "the ability of -synuclein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "synaptic vesicles"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0039065:Synaptic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "regulate"

Phrase: "protein-protein interactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.313: Here we demonstrate that the phosphorylation state of tyrosine 125of -synuclein modulates the activity of PLD. 

Phrase: "Here"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the phosphorylation state of tyrosine 125of -synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the activity of PLD."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C1149851:phospholipase D activity [Molecular Function]
   797   C1149838:phospholipase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.314: A mutation Tyr125 to Phe in -synuclein (Y125F) that mimics dephosphorylation increases the ability of -synuclein to inhibit pervanadate-induced PLD activation. 

Phrase: "A mutation Tyr125 to Phe in -synuclein"

Phrase: "(Y125F"

Phrase: ")"

Phrase: "that"

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "dephosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158884:Dephosphorylation [Molecular Function]
  1000   C3160734:Dephosphorylation [Molecular Function]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the ability of -synuclein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "pervanadate-induced PLD activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]
Processing 00000000.tx.315: This regulatory axis could affect exocytosis, because PLD is thought to be an important component of the exocytotic machinery (49). 

Phrase: "This regulatory axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "could"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "exocytosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "because"

Phrase: "PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an important component of the exocytotic machinery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.316: The discovery of abnormal protein aggregates or accumulation has been described in a number of neurodegenerative diseases. 

Phrase: "The discovery of abnormal protein aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880355:Discovery [Activity]

Phrase: "or"

Phrase: "accumulation"

Phrase: "has"

Phrase: "been"

Phrase: "described in a number of neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1552738:described [Idea or Concept]
Processing 00000000.tx.317: We tried to investigate that the interaction between -synuclein and PLD isozymes has a role in inclusion body formation in PD. 

Phrase: "We"

Phrase: "tried"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "that"

Phrase: "the interaction between -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "PLD isozymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022173:Isozymes [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "a role in inclusion body formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in PD."
Processing 00000000.tx.318: Recently, it was reported that when constructs encoding portions of -synuclein and synphilin-1 are co-transfected in mammalian cells, the cells formed eosinophilic cytosolic inclusions resembling the Lewy bodies of PD (16). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "when"

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "encoding portions of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "co-transfected in mammalian cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1512977:Mammalian Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0024660:Mammalian [Mammal]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "eosinophilic cytosolic inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C3279277:Eosinophilic inclusions [Finding]
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: "resembling"

Phrase: "the Lewy bodies of PD (16"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0085200:Lewy Bodies [Cell Component]
   753   C0242821:bodies [Human]
   753   C1995017:Bodies [Cell Component]
   719 E C0460148:Body [Anatomical Structure]
   719 E C1268086:Body [Anatomical Structure]

Phrase: ")."
Processing 00000000.tx.319: Although -synuclein aggregates by itself in vitro, it may be that aggregation in vivo is facilitated by an associated protein such as synphilin-1. 

Phrase: "Although -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aggregates by itself in vitro,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0205418:Aggregate [Qualitative Concept]

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "that aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "is"

Phrase: "facilitated by an associated protein"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332281:Associated [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "such as synphilin-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.320: When constructs encoding synphilin-1 and full-length -synuclein or the non-A component AD amyloid (NAC) portion of -synuclein were co-transfected, we observed that ~6% of cells had cytosolic phase-dense inclusions. 

Phrase: "When"

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "full-length -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "the non-A component AD amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: ")"

Phrase: "portion of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "co-transfected"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that ~6% of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "cytosolic phase-dense inclusions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.321: Cytosolic inclusions were eosinophilic when stained with H&E. 

Phrase: "Cytosolic inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "were"

Phrase: "eosinophilic"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0333930:Eosinophilic [Functional Concept]
   928 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   928 E C0014467:Eosinophils [Cell]
   928 E C0200638:Eosinophils [Laboratory Procedure]
   928 E C1306759:Eosinophilia [Disease or Syndrome]
   928 E C1636667:Eosinophilia [Disease or Syndrome]
   928 E C2240374:Eosinophilia [Finding]

Phrase: "when"

Phrase: "stained with H&E."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   891   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   781   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.322: In contrast, when constructs encoding PLD isozyme (PLD1 or PLD2) were co-transfected along with -synuclein or NAC, only ~1-2% of cells had eosinophilic inclusions, which is similar to that present in control cells. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "PLD isozyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022173:Isozyme [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PLD1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418641:PLD1 [Gene or Genome]

Phrase: "or"

Phrase: "PLD2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0538283:phospholipase D2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418642:PHOSPHOLIPASE D2 [Gene or Genome]
   861   C1414052:D2 [Gene or Genome]
   861   C1415944:D2 [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "co-transfected along with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "NAC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "only ~1-2% of cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "eosinophilic inclusions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3279277:Eosinophilic inclusions [Finding]
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "similar to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2348205:Similar [Qualitative Concept]

Phrase: "that present in control cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.323: Thus, our data suggest that PLD isozymes may not modulate -synuclein aggregation. 

Phrase: "Thus,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PLD isozymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022173:Isozymes [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modulate -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "synuclein aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.324: In summary, our study suggests that -synuclein modulates the activity of PLD by protein-protein interactions, but this interaction might not be involved in regulation of the formation of cytoplasmic inclusion bodies in mammalian cells. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the activity of PLD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C1149851:phospholipase D activity [Molecular Function]
   797   C1149838:phospholipase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "by protein-protein interactions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704675:Interaction [Functional Concept]

Phrase: "but"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "might"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "involved in regulation of the formation of cytoplasmic inclusion bodies"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   782   C2700430:Cytoplasmic inclusion bodies [Finding]
   777   C1157723:regulation of formation [Molecular Function]
   760   C0007637:Inclusion Bodies [Cell Component]
   760   C0205708:Cytoplasmic inclusion [Cell Component]
       E   Cytoplasmic inclusion body
   757   C0333774:Cytoplasmic bodies [Cell Component]
   739   C0010834:Cytoplasmic [Cell Component]
   739   C0220781:formation [Biologic Function]
   739   C0242821:bodies [Human]
   739   C0439634:formation [Spatial Concept]
   739   C0521449:Cytoplasmic [Body Location or Region]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1314939:Involved [Functional Concept]
   739   C1327622:Regulation [Biologic Function]
   739   C1512693:Inclusion [Qualitative Concept]
   739   C1522492:Formation [Functional Concept]
   739   C1995017:Bodies [Cell Component]
   706 E C0460148:Body [Anatomical Structure]
   706 E C1268086:Body [Anatomical Structure]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.325: However, we cannot rule out the possibility that PLD does modulate -synuclein aggregation in the brain, because the environment of HEK 293cells differs from that of the aged human brain. 

Phrase: "However,"

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "does"

Phrase: "modulate -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "synuclein aggregation in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "because"

Phrase: "the environment of HEK 293cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0014406:Environment [Spatial Concept]

Phrase: "differs from that of the aged human brain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0001779:Aged [Organism Attribute]
   744   C0001792:Aged [Population Group]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0086418:Human [Human]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1999167:aged [Population Group]
Processing 00000000.tx.326: Although the function of both -synuclein and PLD remains largely unknown, identification of binding partners and examination of how and where the complexes form in the cell provide important tools for understanding the physiology of PD.  

Phrase: "Although"

Phrase: "the function of both -synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "PLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "remains"

Phrase: "largely unknown, identification of binding partners"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "examination of how"

Phrase: "and"

Phrase: "where"

Phrase: "the complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "form in the cell"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0007634:Cell [Cell]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1269647:Cell [Cell]
   770   C1522492:Form [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "important tools for understanding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0336791:Tool [Manufactured Object]
   737   C2827396:Tool [Manufactured Object]

Phrase: "the physiology of PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031842:Physiology [Biomedical Occupation or Discipline]
   770   C0031843:physiology [Physiologic Function]
Processing 00000000.tx.327: ACKNOWLEDGEMENTS We thank Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.328: Sung Ho Ryu for providing the GST-PLD expression vector, Dr. 

Phrase: "Sung Ho Ryu for providing"

Phrase: "the GST-PLD expression vector,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.329: C.A.Ross for providing cDNA encoding synphilin-1, Dr. 

Phrase: "C.A.Ross for providing cDNA encoding synphilin-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0812281:c-ros-1 [Gene or Genome]
   742   C0331968:Ross [Health Care Related Organization]
   742   C2699100:Ross [Bird]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.330: Robert L.

Phrase: "Robert L."
Processing 00000000.tx.331: Nussbaum for providing cDNA encoding mutant -synuclein (Y125F), and Dr. 

Phrase: "Nussbaum for providing cDNA encoding mutant -synuclein"

Phrase: "(Y125F"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.332: John H.Exton for helpful comments in the preparation of this manuscript.  

Phrase: "John H.Exton for helpful comments"

Phrase: "in the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of this manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.333: FOOTNOTES * This work was supported by a grant from the Korea Health 21R&D Project, Ministry of Health &Welfare, Republic of Korea (01-PJ1-PG3-20900-0011) and by a research grant from the Ministry of Education (BK21).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a grant"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C1548284:Grant [Idea or Concept]
   737 E C0183683:Support [Medical Device]

Phrase: "from the Korea Health 21R&D Project,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1709701:Project [Conceptual Entity]

Phrase: "Ministry of Health &Welfare,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037440:welfare [Self-help or Relief Organization]

Phrase: "Republic of Korea"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0022773:Republic of Korea [Geographic Area]
   827   C0022771:Korea [Geographic Area]
   755 E C1556095:Korean [Population Group]

Phrase: "(01-PJ1-PG3-20900-0011"

Phrase: ")"

Phrase: "and by a research grant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0260206:research grant [Research Activity]
   760   C0018173:Grant [Quantitative Concept]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1515981:And [Idea or Concept]
   760   C1548284:Grant [Idea or Concept]

Phrase: "from the Ministry"

Phrase: "of Education"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "(BK21"

Phrase: ")."
Processing 00000000.tx.334: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.335: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.336: Section 1734solely to indicate this fact. j To whom correspondence should be addressed. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact. j To whom correspondence"

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.337: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.338: 82-2-590-1165; 

Phrase: "82-2-590-1165"

Phrase: ";"
Processing 00000000.tx.339: Fax: 82-2-532-9575; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "82-2-532-9575"

Phrase: ";"
Processing 00000000.tx.340: E-mail: dsmin@cmc.cuk.ac.kr. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "dsmin@cmc.cuk.ac.kr."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0022773:KR [Geographic Area]
Processing 00000000.tx.341: Published, JBC Papers in Press, January 30,2002,DOI 10.1074/jbc.M110414200  ABBREVIATIONS The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "January 30,"

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M110414200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.342: PD, Parkinson's disease; 

Phrase: "PD,"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: ";"
Processing 00000000.tx.343: PLD, phospholipase D; 

Phrase: "PLD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phospholipase D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031670:Phospholipase D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.344: PLC, phospholipase C; 

Phrase: "PLC,"

Phrase: "phospholipase C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.345: PMA, phorbol 12-myristate 13-acetate; 

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "phorbol 12-myristate 13-acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.346: PKC, protein kinase C ; DMEM, Dulbecco's modified Eagle's medium; 

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; DMEM,"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.347: HEK cells, human embryonic kidney cells; 

Phrase: "HEK cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "human embryonic kidney cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.348: NAC, non-A component of Alzheimer's disease plaques; 

Phrase: "NAC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "non-A component of Alzheimer's disease plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.349: GST, glutathione S-transferase; 

Phrase: "GST,"

Phrase: "glutathione S-transferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.350: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.351: H&E, hematoxylin and eosin; 

Phrase: "H&E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "hematoxylin and eosin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.352: wt, wild-type.  

Phrase: "wt, wild-type."
Processing 00000000.tx.353: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.354: Dickson, D. 

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.355: W. 

Phrase: "W."
Processing 00000000.tx.356: (2001) Curr. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.357: Opin. 

Phrase: "Opin."
Processing 00000000.tx.358: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.359: 14, 423-432[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "14,"

Phrase: "423-432"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.360: Goedert, M. 

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.361: (2001) Nat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.362: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.363: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.364: 2, 492-501[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "492-501"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.365: Baba, M., Nakajo, S., Tu, P.H., Tomita, T., Nakaya, K., Lee, V. 

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakaya,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.366: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.367: Q., and Iwatsubo, T. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.368: (1998) Am. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.369: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.370: 152, 879-884[Abstract] 4. 

Phrase: "152,"

Phrase: "879-884"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 4."
Processing 00000000.tx.371: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.372: G., Schmidt, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: L., Lee, V. 

Phrase: "L., Lee,"

Phrase: "V."
Processing 00000000.tx.374: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.375: Q., Jakes, R., and Goedert, M. 

Phrase: "Q., Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.376: (1997) Nature 388, 839-840[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "839-840"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.377: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.378: G., Growther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Growther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.379: A., Jakes, R., Hasegawa, M., and Goedert, M. 

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.380: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.381: Natl. 

Phrase: "Natl."
Processing 00000000.tx.382: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.383: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.384: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.385: 95, 6469-6473[Abstract/Free FullText] 6. 

Phrase: "95,"

Phrase: "6469-6473"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.386: Tu, P. 

Phrase: "Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.387: H., Galvin, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Galvin,"

Phrase: "J."
Processing 00000000.tx.388: E., Baba, M., Giasson, B., Tomita, T., leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. 

Phrase: "E.,"

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Giasson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "leight,"

Phrase: "S."

Phrase: ","

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.389: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.390: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.391: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.392: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.393: 44, 415-422[Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "44,"

Phrase: "415-422"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.394: Dickson, D. 

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.395: W., Liu, W., Hardy, J., Farrer, M., Mehta, N., Uitti, R., Mark, M., Zimmerman, T., Golbe, L., Sage, J., Sima, A., D'Amato, C., Albin, R., Gilman, S., and Yen, S. 

Phrase: "W., Liu,"

Phrase: "W.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Mehta,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Uitti,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mark,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]
   928 E C1706089:Marked [Qualitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Zimmerman,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Golbe,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1122976:Sage [Food]
  1000   C3265310:sage [Organic Chemical,Pharmacologic Substance]

Phrase: "J.,"

Phrase: "Sima,"

Phrase: "A.,"

Phrase: "D'"

Phrase: "Amato,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Albin,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gilman,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.396: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.397: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.398: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.399: 155, 1241-1251[Abstract/Free FullText] 8. 

Phrase: "155,"

Phrase: "1241-1251"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.400: Polymeropoulus, M. 

Phrase: "Polymeropoulus,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.401: H., Lavedan, C., Leroy, E., Ide, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.402: E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. 

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stenroos,"

Phrase: "E."
Processing 00000000.tx.403: S., Chandrasekharappa, S., Athanassiadou, A., Papapetropolous, T., Johnson, W. 

Phrase: "S."

Phrase: ","

Phrase: "Chandrasekharappa,"

Phrase: "S."

Phrase: ","

Phrase: "Athanassiadou,"

Phrase: "A.,"

Phrase: "Papapetropolous,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Johnson,"

Phrase: "W."
Processing 00000000.tx.404: G., Lazzarini, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "A."
Processing 00000000.tx.405: M., Duvoisin, R. 

Phrase: "M."

Phrase: ","

Phrase: "Duvoisin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.406: C., Di, Iorio, G., Golbe, L. 

Phrase: "C., Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "Iorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Golbe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.407: I., and Nussbaum, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.408: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.409: (1997) Science 276, 2045-2047[Abstract/Free FullText] 9. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 276,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2045-2047"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.410: Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przunt, H., Epplen, J. 

Phrase: "Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przunt,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J."
Processing 00000000.tx.411: T., Schols, L., and Riess, O. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schols,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.412: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.413: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.414: 18, 106-108[Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "18,"

Phrase: "106-108"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.415: Feany, M. 

Phrase: "Feany,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.416: B., and Bender, W. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Bender,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0491941:BENDER [Medical Device]

Phrase: "W."
Processing 00000000.tx.417: W. 

Phrase: "W."
Processing 00000000.tx.418: (2000) Nature 202, 394-398 11. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 202,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "394-398 11."
Processing 00000000.tx.419: Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., and Mucke, L. 

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Rockenstein,"

Phrase: "E.,"

Phrase: "Veinbergs,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Hashimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Sagara,"

Phrase: "Y.,"

Phrase: "Sisk,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.420: (2000) Science 287, 1265-1269[Abstract/Free FullText] 12. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 287,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1265-1269"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.421: Davidson, W. 

Phrase: "Davidson,"

Phrase: "W."
Processing 00000000.tx.422: S., Jonas, A., Clayton, D. 

Phrase: "S."

Phrase: ","

Phrase: "Jonas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1652689:Jonas [Eukaryote]

Phrase: "A.,"

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.423: F., and George, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.424: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.425: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.426: Biol. 

Phrase: "Biol."
Processing 00000000.tx.427: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.428: 273, 9443-9449[Abstract/Free FullText] 13. 

Phrase: "273,"

Phrase: "9443-9449"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.429: Weinreb, P. 

Phrase: "Weinreb,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.430: H., Zhen, W., Poon, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zhen,"

Phrase: "W.,"

Phrase: "Poon,"

Phrase: "A."
Processing 00000000.tx.431: W., Conway, K. 

Phrase: "W., Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.432: A., and Lansbury, P. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.433: T.J. 

Phrase: "T.J."
Processing 00000000.tx.434: (1996) Biochemstry 35, 13709-13715[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochemstry 35,"

Phrase: "13709-13715"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.435: Jensen, P. 

Phrase: "Jensen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.436: H., Hager, H., Nielsen, M., Hojrup, P., Gliemann, J., and Jakes, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hager,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nielsen,"

Phrase: "M."

Phrase: ","

Phrase: "Hojrup,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gliemann,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Jakes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.437: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.438: Biol. 

Phrase: "Biol."
Processing 00000000.tx.439: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.440: 274, 25481-25489[Abstract/Free FullText] 15. 

Phrase: "274,"

Phrase: "25481-25489"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.441: Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J., and Wolozin, B. 

Phrase: "Ostrerova,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Mehta,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Choi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.442: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.443: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.444: 19, 5782-5791[Abstract/Free FullText] 16. 

Phrase: "19,"

Phrase: "5782-5791"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.445: Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. 

Phrase: "Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Kaminsky,"

Phrase: "Z.,"

Phrase: "Guo,"

Phrase: "X.,"

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.446: H., Amaravi, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Amaravi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.447: K., Kleiderlein, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kleiderlein,"

Phrase: "J."
Processing 00000000.tx.448: J., Margolis, R. 

Phrase: "J.,"

Phrase: "Margolis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.449: L., Troncoso, J. 

Phrase: "L., Troncoso,"

Phrase: "J."
Processing 00000000.tx.450: C., Lanahan, A. 

Phrase: "C., Lanahan,"

Phrase: "A."
Processing 00000000.tx.451: A., Worley, P. 

Phrase: "A.,"

Phrase: "Worley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.452: F., Dawson, V. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V."
Processing 00000000.tx.453: L., Dawson, T. 

Phrase: "L., Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551910:Dawson [Language]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.454: M., and Ross, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."
Processing 00000000.tx.455: A. 

Phrase: "A."
Processing 00000000.tx.456: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.457: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.458: 22, 110-114[CrossRef][Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "22,"

Phrase: "110-114"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.459: Iwata, A., Miura, S., Kanazawa, I., Sawada, M., and Nukina, N. 

Phrase: "Iwata,"

Phrase: "A.,"

Phrase: "Miura,"

Phrase: "S."

Phrase: ","

Phrase: "Kanazawa,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sawada,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Nukina,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.460: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.461: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.462: 72, 239-252[CrossRef] 18. 

Phrase: "72,"

Phrase: "239-252"

Phrase: "[CrossRef"

Phrase: "] 18."
Processing 00000000.tx.463: Ghee, M., Fournier, A., and Mallet, J. 

Phrase: "Ghee,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017517:Ghee [Food,Lipid]

Phrase: "M."

Phrase: ","

Phrase: "Fournier,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Mallet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181716:MALLET [Medical Device]

Phrase: "J."
Processing 00000000.tx.464: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.465: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.466: 75, 2221-2224[CrossRef][Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "75,"

Phrase: "2221-2224"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.467: Clayton, D. 

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.468: F., and George, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.469: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.470: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.471: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.472: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.473: 58, 120-129[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "58,"

Phrase: "120-129"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.474: Jenco, J. 

Phrase: "Jenco,"

Phrase: "J."
Processing 00000000.tx.475: M., Rawlingson, A., Daniels, B., and Morris, A. 

Phrase: "M."

Phrase: ","

Phrase: "Rawlingson,"

Phrase: "A.,"

Phrase: "Daniels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331799:Daniels [Health Care Related Organization]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Morris,"

Phrase: "A."
Processing 00000000.tx.476: J. 

Phrase: "J."
Processing 00000000.tx.477: (1998) Biochemistry 37, 4901-4909[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4901-4909"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.478: Hammond, S. 

Phrase: "Hammond,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.479: M., Jenco, J. 

Phrase: "M."

Phrase: ","

Phrase: "Jenco,"

Phrase: "J."
Processing 00000000.tx.480: M., Nakashima, S., Cadwallader, K., Gu, Q-M., Cook, S., Nozawa, Y., Prestwich, G. 

Phrase: "M."

Phrase: ","

Phrase: "Nakashima,"

Phrase: "S."

Phrase: ","

Phrase: "Cadwallader,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gu,"

Phrase: "Q-"

Phrase: "M."

Phrase: ","

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "S."

Phrase: ","

Phrase: "Nozawa,"

Phrase: "Y.,"

Phrase: "Prestwich,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.481: D., Frohman, M. 

Phrase: "D."

Phrase: ","

Phrase: "Frohman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.482: A., and Morris, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Morris,"

Phrase: "A."
Processing 00000000.tx.483: J. 

Phrase: "J."
Processing 00000000.tx.484: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.485: Biol. 

Phrase: "Biol."
Processing 00000000.tx.486: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.487: 272, 3860-3868[Abstract/Free FullText] 22. 

Phrase: "272,"

Phrase: "3860-3868"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.488: Colley, W. 

Phrase: "Colley,"

Phrase: "W."
Processing 00000000.tx.489: C., Sung, R., Jenco, R. 

Phrase: "C., Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037173:SING [Geographic Area]
   827   C0234857:sing [Individual Behavior]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jenco,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.490: L., Hammond, S. 

Phrase: "L., Hammond,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.491: M., Altshuller, Y., Bar-Sagi, D., Morris, A. 

Phrase: "M."

Phrase: ","

Phrase: "Altshuller,"

Phrase: "Y.,"

Phrase: "Bar-Sagi,"

Phrase: "D."

Phrase: ","

Phrase: "Morris,"

Phrase: "A."
Processing 00000000.tx.492: J., and Frohman, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Frohman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.493: A. 

Phrase: "A."
Processing 00000000.tx.494: (1997) Curr. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.495: Biol. 

Phrase: "Biol."
Processing 00000000.tx.496: 7, 191-201[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "7,"

Phrase: "191-201"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.497: Min, D. 

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "D."
Processing 00000000.tx.498: S., Park, S. 

Phrase: "S."

Phrase: ","

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.499: K., and Exton, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Exton,"

Phrase: "J."
Processing 00000000.tx.500: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.501: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.502: Biol. 

Phrase: "Biol."
Processing 00000000.tx.503: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.504: 273, 7044-7051[Abstract/Free FullText] 24. 

Phrase: "273,"

Phrase: "7044-7051"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.505: Sung, T. 

Phrase: "Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.506: C., Zhang, Y., Morris, A. 

Phrase: "C., Zhang,"

Phrase: "Y.,"

Phrase: "Morris,"

Phrase: "A."
Processing 00000000.tx.507: J., and Frohman, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Frohman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.508: A. 

Phrase: "A."
Processing 00000000.tx.509: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.510: Biol. 

Phrase: "Biol."
Processing 00000000.tx.511: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.512: 274, 3659-3666[Abstract/Free FullText] 25. 

Phrase: "274,"

Phrase: "3659-3666"

Phrase: "[Abstract/Free FullText"

Phrase: "] 25."
Processing 00000000.tx.513: Exton, J. 

Phrase: "Exton,"

Phrase: "J."
Processing 00000000.tx.514: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.515: (1997) Physiol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Physiol."
Processing 00000000.tx.516: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.517: 77, 303-320[Abstract/Free FullText] 26. 

Phrase: "77,"

Phrase: "303-320"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.518: Klein, J., Chalifa, V., Liscovitch, M., and Loffelholz, K. 

Phrase: "Klein,"

Phrase: "J.,"

Phrase: "Chalifa,"

Phrase: "V.,"

Phrase: "Liscovitch,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Loffelholz,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.519: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.520: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.521: 6, 1445-1455 27. 

Phrase: "6,"

Phrase: "1445-1455 27."
Processing 00000000.tx.522: Min, D. 

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "D."
Processing 00000000.tx.523: S., Ahn, B.-H., Rhie, D.-J., Yoon, S.-H., Hahn, S. 

Phrase: "S."

Phrase: ","

Phrase: "Ahn,"

Phrase: "B.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Rhie,"

Phrase: "D.-J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yoon,"

Phrase: "S.-"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hahn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.524: J., Kim, M.-S., and Jo, Y-H. 

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "M.-S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Jo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022418:JO [Geographic Area]

Phrase: "Y-H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.525: (2001) Neuropharmacology 41, 384-391[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neuropharmacology 41,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027896:Neuropharmacology [Biomedical Occupation or Discipline]

Phrase: "384-391"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.526: Lee, M.-Y., Jo, Y.-H., Chun, M.-H., Chung, J.-W., Kim, M.-S., and Min, D. 

Phrase: "Lee,"

Phrase: "M.-"

Phrase: "Y.,"

Phrase: "Jo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022418:JO [Geographic Area]

Phrase: "Y.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Chun,"

Phrase: "M.-"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chung,"

Phrase: "J.-W., Kim,"

Phrase: "M.-S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "D."
Processing 00000000.tx.527: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.528: (2000) Brain Res. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.529: 864, 52-59[CrossRef][Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "864,"

Phrase: "52-59"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.530: Lee, C., Kim, S. 

Phrase: "Lee,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.531: R., Chung, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Chung,"

Phrase: "J."
Processing 00000000.tx.532: K., Frohman, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Frohman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.533: A., Kilimann, M. 

Phrase: "A.,"

Phrase: "Kilimann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.534: W., and Rhee, S. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Rhee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.535: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.536: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.537: Biol. 

Phrase: "Biol."
Processing 00000000.tx.538: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.539: 275, 18751-18758[Abstract/Free FullText] 30. 

Phrase: "275,"

Phrase: "18751-18758"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.540: Bradford, M. 

Phrase: "Bradford,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.541: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.542: (1976) Anal. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.543: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.544: 72, 248-254[CrossRef][Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "72,"

Phrase: "248-254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.545: Bligh, E. 

Phrase: "Bligh,"

Phrase: "E."
Processing 00000000.tx.546: G., and Dyer, W. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Dyer,"

Phrase: "W."
Processing 00000000.tx.547: J. 

Phrase: "J."
Processing 00000000.tx.548: (1959) Can. 

Phrase: "(1959"

Phrase: ")"

Phrase: "Can."
Processing 00000000.tx.549: J.

Phrase: "J."
Processing 00000000.tx.550: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.551: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.552: 37, 911-917 32. 

Phrase: "37,"

Phrase: "911-917 32."
Processing 00000000.tx.553: David, L. 

Phrase: "David,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.554: S., Robert, D. 

Phrase: "S."

Phrase: ","

Phrase: "Robert,"

Phrase: "D."
Processing 00000000.tx.555: G., and Leslie, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Leslie,"

Phrase: "A."
Processing 00000000.tx.556: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.557: (1998) Cells: A Laboratory Manual , pp. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "A Laboratory Manual , pp."
Processing 00000000.tx.558: 98.6-98.13, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 33. 

Phrase: "98.6-98.13,"

Phrase: "Cold Spring Harbor Laboratory Press,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY 33."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]
Processing 00000000.tx.559: Huyer, G., Liu, S., Kelly, J., Moffat, J., Payette, P., Kennedy, B., Tsaprailis, G., Gresser, M. 

Phrase: "Huyer,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Liu,"

Phrase: "S."

Phrase: ","

Phrase: "Kelly,"

Phrase: "J.,"

Phrase: "Moffat,"

Phrase: "J.,"

Phrase: "Payette,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kennedy,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tsaprailis,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gresser,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.560: J., and Ramachandran, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Ramachandran,"

Phrase: "C."
Processing 00000000.tx.561: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.562: Biol. 

Phrase: "Biol."
Processing 00000000.tx.563: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.564: 272, 843-851[Abstract/Free FullText] 34. 

Phrase: "272,"

Phrase: "843-851"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.565: Min, D. 

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "D."
Processing 00000000.tx.566: S., Kim, E.-G., and Exton, J. 

Phrase: "S."

Phrase: ","

Phrase: "Kim,"

Phrase: "E.-G."

Phrase: ","

Phrase: "and"

Phrase: "Exton,"

Phrase: "J."
Processing 00000000.tx.567: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.568: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.569: Biol. 

Phrase: "Biol."
Processing 00000000.tx.570: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.571: 273, 29986-29994[Abstract/Free FullText] 35. 

Phrase: "273,"

Phrase: "29986-29994"

Phrase: "[Abstract/Free FullText"

Phrase: "] 35."
Processing 00000000.tx.572: Rumenapp, U., Schmidt, M., Olesch, S., Ott, S., Eichel-Streiber, C. 

Phrase: "Rumenapp,"

Phrase: "U.,"

Phrase: "Schmidt,"

Phrase: "M."

Phrase: ","

Phrase: "Olesch,"

Phrase: "S."

Phrase: ","

Phrase: "Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "S."

Phrase: ","

Phrase: "Eichel-Streiber,"

Phrase: "C."
Processing 00000000.tx.573: V., and Jakobs, K. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Jakobs,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.574: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.575: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.576: J. 

Phrase: "J."
Processing 00000000.tx.577: 334, 625-631[Medline] [OrderarticleviaInfotrieve] 36. 

Phrase: "334,"

Phrase: "625-631"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 36."
Processing 00000000.tx.578: Le Stunff, H., Dokhac, L., and Harbon, S. 

Phrase: "Le Stunff,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dokhac,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Harbon,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.579: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.580: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.581: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.582: Ther. 

Phrase: "Ther."
Processing 00000000.tx.583: 292, 629-637[Abstract/Free FullText] 37. 

Phrase: "292,"

Phrase: "629-637"

Phrase: "[Abstract/Free FullText"

Phrase: "] 37."
Processing 00000000.tx.584: Ellis, C. 

Phrase: "Ellis,"

Phrase: "C."
Processing 00000000.tx.585: E., Schwartzberg, P. 

Phrase: "E.,"

Phrase: "Schwartzberg,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.586: L., Grider, T. 

Phrase: "L., Grider,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.587: L., Fink, D. 

Phrase: "L., Fink,"

Phrase: "D."
Processing 00000000.tx.588: W., and Nussbaum, R. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.589: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.590: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.591: Biol. 

Phrase: "Biol."
Processing 00000000.tx.592: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.593: 276, 3879-3884[Abstract/Free FullText] 38. 

Phrase: "276,"

Phrase: "3879-3884"

Phrase: "[Abstract/Free FullText"

Phrase: "] 38."
Processing 00000000.tx.594: Maroteaux, L., and Scheller, R. 

Phrase: "Maroteaux,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Scheller,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.595: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.596: (1991) Brain Res. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.597: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.598: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.599: 11, 335-343[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "11,"

Phrase: "335-343"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.600: Kholodilov, N. 

Phrase: "Kholodilov,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.601: G., Neystat, M., Oo, T.F., Lo, S.E., Larsen, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Neystat,"

Phrase: "M."

Phrase: ","

Phrase: "Oo,"

Phrase: "T.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lo,"

Phrase: "S."

Phrase: "E.,"

Phrase: "Larsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.602: E., Sulzer, D., and Burke, R. 

Phrase: "E.,"

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Burke"

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.603: E. 

Phrase: "E."
Processing 00000000.tx.604: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.605: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.606: 73, 2586-2599[CrossRef][Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "73,"

Phrase: "2586-2599"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.607: Forno, L. 

Phrase: "Forno,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.608: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.609: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.610: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.611: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.612: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.613: 55, 259-272[Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "259-272"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.614: Silva, H. 

Phrase: "Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   928   C0144237:Silvan [Organic Chemical]
   907 E C0043217:Wood [Substance]
   907 E C0442548:Woods [Geographic Area]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.615: R., Khan, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Khan,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.616: L., and Wood, N. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.617: W. 

Phrase: "W."
Processing 00000000.tx.618: (2000) Curr. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.619: Opin. 

Phrase: "Opin."
Processing 00000000.tx.620: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.621: Dev. 

Phrase: "Dev."
Processing 00000000.tx.622: 10, 292-298[CrossRef][Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "10,"

Phrase: "292-298"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.623: Kanfer, J. 

Phrase: "Kanfer,"

Phrase: "J."
Processing 00000000.tx.624: N., Singh, I. 

Phrase: "N., Singh,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.625: N., Pettegrew, J. 

Phrase: "N., Pettegrew,"

Phrase: "J."
Processing 00000000.tx.626: W., McCartney, D. 

Phrase: "W., McCartney,"

Phrase: "D."
Processing 00000000.tx.627: G., and Sorrentino, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sorrentino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.628: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.629: Lipid Mediat. 

Phrase: "Lipid Mediat."
Processing 00000000.tx.630: Cell Signal. 

Phrase: "Cell Signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.631: 14, 361-363[CrossRef][Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "14,"

Phrase: "361-363"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.632: Lavedan, C. 

Phrase: "Lavedan,"

Phrase: "C."
Processing 00000000.tx.633: (1998) Genome Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genome Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.634: 8, 871-880[Abstract/Free FullText] 44. 

Phrase: "8,"

Phrase: "871-880"

Phrase: "[Abstract/Free FullText"

Phrase: "] 44."
Processing 00000000.tx.635: Xu, Y., Seet, L.-F., Hanson, B., and Hong, W. 

Phrase: "Xu,"

Phrase: "Y.,"

Phrase: "Seet,"

Phrase: "L.-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Hanson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Hong,"

Phrase: "W."
Processing 00000000.tx.636: (2001) Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.637: J. 

Phrase: "J."
Processing 00000000.tx.638: 360, 513-530[CrossRef][Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "360,"

Phrase: "513-530"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.639: Gurd, J. 

Phrase: "Gurd,"

Phrase: "J."
Processing 00000000.tx.640: W. 

Phrase: "W."
Processing 00000000.tx.641: (1997) Neurochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.642: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.643: 31, 645-649 46. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "645-649 46."
Processing 00000000.tx.644: O'Dell, T. 

Phrase: "O'Dell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.645: J., Kandel, E. 

Phrase: "J.,"

Phrase: "Kandel,"

Phrase: "E."
Processing 00000000.tx.646: R., and Grant, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.647: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.648: (1991) Nature 353, 558-560[CrossRef][Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Nature 353,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "558-560"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.649: Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W.H., Castillo, P. 

Phrase: "Abeliovich,"

Phrase: "A.,"

Phrase: "Schmitz,"

Phrase: "Y.,"

Phrase: "Farinas,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Choi-Lundberg,"

Phrase: "D."

Phrase: ","

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "W.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Castillo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.650: E., Shinsky, N., Verdugo, J. 

Phrase: "E.,"

Phrase: "Shinsky,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Verdugo,"

Phrase: "J."
Processing 00000000.tx.651: M., Armanini, M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D., and Rosenthal, A. 

Phrase: "M."

Phrase: ","

Phrase: "Armanini,"

Phrase: "M."

Phrase: ","

Phrase: "Ryan,"

Phrase: "A.,"

Phrase: "Hynes,"

Phrase: "M."

Phrase: ","

Phrase: "Phillips,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Rosenthal,"

Phrase: "A."
Processing 00000000.tx.652: (2000) Neuron 25, 239-252[Medline] [OrderarticleviaInfotrieve] 48. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neuron 25,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "239-252"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 48."
Processing 00000000.tx.653: Iwai, A., Yoshimoto, M., Masliah, E., and Saitoh, T. 

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.654: (1995) Biochemistry 34, 10139-10145[Medline] [OrderarticleviaInfotrieve] 49. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochemistry 34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10139-10145"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 49."
Processing 00000000.tx.655: Vitale, N., Caumont, A-S., Chasserot-Golaz, S., Du, G., Wu, S., Sciorra, V. 

Phrase: "Vitale,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Caumont,"

Phrase: "A-S.,"

Phrase: "Chasserot-Golaz,"

Phrase: "S."

Phrase: ","

Phrase: "Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "S."

Phrase: ","

Phrase: "Sciorra,"

Phrase: "V."
Processing 00000000.tx.656: A., Morris, A. 

Phrase: "A.,"

Phrase: "Morris,"

Phrase: "A."
Processing 00000000.tx.657: J., Frohman, M. 

Phrase: "J.,"

Phrase: "Frohman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.658: A., and Bader, M-F. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Bader,"

Phrase: "M-"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.659: (2001) EMBO J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.660: 20, 2424-2434[Abstract/Free FullText] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "20,"

Phrase: "2424-2434"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

